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Abdominal pain (AP) is a common symptom among children and adults.  Irritable Bowel 
Syndrome (IBS) is reported to be one of the most frequent types of AP. Comorbid chronic 
pain and mental health problems are common in AP and IBS. There is increasing knowledge 
of a variety of biopsychosocial mechanisms contributing to AP and IBS. Among these, 
increased visceral and widespread pain sensitivity are factors possibly contributing to 
triggering and maintaining pain symptoms. However, it is not clear to what degree the 
association between widespread hyperalgesia and IBS is related to confounding with 
comorbid chronic pain and mental health. All previous IBS pain sensitivity studies have been 
limited to clinical samples, a majority only including premenopausal female adult patients, 
and there are no studies of community samples, including both sexes and pediatric 
populations.  The main aim of this thesis was therefore to analyze the association of IBS and 
widespread pain sensitivity among adolescents and adults in the general population, 
controlling for sex, age, comorbid chronic pain and psychological distress.  The second aim 
was to describe the association between specific abdominal pain dimensions, bowel 
symptoms and other chronic pain with depression among adolescents with chronic 
abdominal pain and IBS.  
Methods 
More than ten thousand adults (n = 10 566, age 30-87) and almost one thousand 
adolescents (n = 961, age 15-17) completed questionnaires and pain sensitivity assessment 
(heat, pressure and cold-pressor pain) in two cross sectional population based studies 
(2007/08 and 2010/11 respectively). Associations between self-reported symptoms of IBS 
and measured pain sensitivity were studied, controlling for sex, age, comorbid chronic pain 
and psychological distress (the Hopkins Symptom Check List).  Further, associations between 
IBS, AP and different AP symptom dimensions with depression (the Short Mood and Feelings 






The adult and adolescent IBS prevalence was 5.3 % and 8.2 % respectively (Rome II and III 
criteria respectively).   
Among the adolescents pain thresholds were significantly lower in IBS cases compared to 
controls. The differences remained significant after adjusting for sex and comorbid pain 
(mean pressure difference fingernail = - 62 kPa with 95 % CI = -109 to -15,  shoulder = - 46 
kPa with 95 % CI = - 78 to – 13, mean heat difference = - 0.8 o C with 95 % CI = - 1.6 to - 0.04 
and mean sum z-score difference =  - 0.4 with 95 % CI = - 0.6 to - 0.17) , whereas only heat 
pain and mean sum z-score threshold difference  were significant when additional adjust for 
mental distress was performed. 
Similar findings for heat pain threshold were made for adults, where differences remained 
significant after adjusting for sex, age, comorbid chronic pain and psychological distress 
(mean difference: - 0.5 o C with 95 % CI = - 0.8 to - 0.1). However no difference in pressure 
pain supra-threshold was found after adjustments for sex and comorbid pain. Increased pain 
intensity (mean numeric rating score, 0 to 10, of 5.9 in IBS vs. 5.3 in controls, p < .01) and 
lower pain tolerance was found in the cold-pressor test (Hazard ratio = 1.3, with 95 % CI = 
1.1 to 1.5) among adult IBS cases after the same adjustments, while no pain tolerance 
differences between adolescent IBS cases and controls were found. Both adolescent and 
adult participants with IBS and severe abdominal pain had the lowest heat pain thresholds. 
Among adults, these participants also had the highest pain ratings and lowest pain tolerance 
in the cold-pressor test.  
Increased symptoms of depression were found among adolescents with both monthly 
abdominal pain (20.5 %) and IBS (24.7 %) compared to controls (8.1 %, both p < 0.01). In the 
multiple logistic regression analyses AP pain intensity and widespread pain distribution were 
significantly associated with depression (severe vs. mild pain: Odds ratio = 4.0, with 95 % CI = 
1.5 to 10.7, multiple vs. single site AP: Odds ratio = 5.5 with 95 % CI = 2.6 to 11.8 and 
comorbid non-AP: Odds ratio = 3.3 with 95 % CI = 1.6 to 6.8 respectively). In contrast, sex 
and other abdominal symptoms, including those symptoms that distinguish IBS from other 





This is the first report documenting widespread hyperalgesia among adolescent and adult 
individuals with symptoms of IBS in the general population. Results were found to be 
independent of sex, comorbid pain and psychological distress.  Increased pain sensitivity 
may contribute in triggering and maintaining chronic pain, but prospective studies are 
needed to examine these possible causal relationships. 
The prevalence of depression is considerably increased among adolescents with AP and IBS 
in the general population, in particular among adolescents with AP reporting severe and 
widespread abdominal pain, and among adolescents reporting comorbid chronic pain in 
other body sites. Evaluating these pain symptom dimensions may be of value for identifying 
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1.1. Functional abdominal pain and Irritable Bowel Syndrome  
The International Association for the Study of Pain (IASP) defines pain as: “An unpleasant 
sensory and emotional experience associated with actual or potential tissue damage, or 
described in terms of such damage”.1 Pain is always subjective, an individual unpleasant 
sensation, and therefore also an emotional experience. The unpleasant sensation is defined 
as pain irrespectively of cause and also if identifiable tissue damage or potential tissue 
damage is absent. Acute pain is one of our most important sensations to reduce and avoid 
tissue damage. In the medical literature, the definition of chronic pain in general and of 
specific chronic pain conditions is less consistent, regarding both the duration and frequency 
of the pain symptoms. 2,3  Acute pain is often related to peripheral inflammation or tissue 
damage (nociceptive input), whereas these peripheral factors are often less prominent or 
non-identifiable in many chronic pain patients.4   
Functional pain and functional pain syndromes are characterized by chronic pain without 
identifiable structural, inflammatory, or biochemical abnormalities that could fully explain 
the symptoms.  Functional abdominal pain and Irritable Bowel Syndrome (IBS) are in the 
same way basically defined by the patients’ symptoms and are referred as disorders rather 
than diseases with an organic cause.5   
Diagnosing functional abdominal pain and IBS remains a challenge with the absence of 
physical or anatomical markers.  For more effective diagnosis of the different functional 
gastrointestinal disorders (FGIDs) a number symptom-based diagnostic criteria have been 
developed over the last 25 years and revised several times since the first Manning criteria 
for IBS of 1978.6 In 1958 Apley and Naish defined recurrent abdominal pain (RAP) in a child 
as “at least three bouts of pain, severe enough to affect the child’s activities, during at least 
a three-month period with attacks continuing the preceding year”.7 This RAP definition is 
widely adopted with many reports of the condition in the medical literature,8 but in recent 
years it has been increasingly replaced by the classification system for FGIDs. In contrast to 
the FGID criteria8, the RAP definition does not exclude organic diseases, and RAP is therefore 
a broader term and not exclusively a functional pain disorder. 
One of the important roles of the classification system for FGIDs is to improve clinical 
diagnosis, distinguishing among different FGIDs from each other and from possible organic 
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diseases.9  An additional aim of more accurate diagnostic, symptom-based criteria has been 
to improve the management and treatment of the FGIDs, in contrast to handling FGID as an 
exclusion diagnosis without available specific treatment or treating it as a psychosomatic 
disorder of mainly psychiatric origin.  
Better classification systems have also led to increased research in the FGID field, with 
increased knowledge of the prevalence, comorbidity, and psychosocial consequences of the 
disorders.10,11 Furthermore, increased attention to, and interest in the FGIDs have led to 
improved evidence of possible pathophysiological mechanisms,5,12-16 which has also led to 
discussion on the origin of the disorders and if they actually are functional or organic by 
nature.9   
The number of FGIDs has increased as the classification  criteria have been revised; the latest  
criteria— the Rome III criteria of 2006—include 28 abdominal pain and bowel disorders for 
adults and 17 for children.5 The system is organized by the anatomical localization of the 
symptoms (e.g., esophageal, stomach-duodenum, bowel, and anorectal symptoms). In the 
pediatric Rome criteria there are, in addition, age-specific FGID disorders (infant/ toddler 
and child/adolescent).  
IBS is one of the most common FGIDs and is characterized by abdominal pain or discomfort, 
associated with altered bowel movements.9,17 The symptoms are not very specific and mimic 
several organic gastroenterological diseases; IBS is for the same reason a clinical exclusion 
diagnosis.  Still, the symptom-based IBS criteria perform fairly to moderately well compared 
to clinical IBS diagnostics, at least when alarm symptoms of organic diseases are included.18 
In one validation study of the different IBS criteria, the sensitivity ranged from 68.8% to 
95.8% and specificity from 70.6% to 79.5% compared to clinical IBS diagnostics.19 The 
Manning criteria included most clinical cases but were also the least specific. Few differences 
were found within the Rome criteria, but the Rome III criteria were found to be most 
specific.  For children there are few similar validation studies of the Rome criteria for FGIDs, 
but most children referred to outpatient clinics with abdominal pain are reported to have a 
functional disorder according to the Rome criteria, with IBS as the most frequent.20,21   
Most validation studies are done at specialized gastroenterologist clinics and few in primary 
care, where most patients with IBS are diagnosed and treated. The IBS Rome III criteria is in 
one study reported to identify three of four patients that had an IBS diagnosis by their 
general practitioner,22 but others have reported poorer agreement between the IBS criteria 
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and clinical diagnoses in primary care.23   To our knowledge, the question remains 
unanswered as to what degree IBS symptoms in the general population correspond to a 
clinical IBS diagnosis.    
As mentioned, the diagnostic criteria of IBS have changed over time. The cardinal and 
associated symptoms are the same, but the criteria diverge somewhat, considering the 
symptom frequency and duration to be more inclusive and specific for IBS (differences 
between the Rome II and III criteria are described in the table below). This is somewhat 
complicated by discrepancies in the diagnostic criteria and the IBS questionnaire module. 
The questionnaire was mainly developed for research and is not a diagnostic tool, because 

























Table 1 The Rome Criteria for IBS 
Rome  








Abdominal pain or discomfort At least once per 
week  
(aR II, pR II and  
pR III)* 
 
At least 3 days 
per month (aR III) 
 
Last 3 months 
(aR II and pR II 
and aR III)**  
  
Last 2 months  
(pR III) 
Within last year 
(aR II)  
 
Within last 6 
months (aR III) 
 
Not defined in 
Pediatric Rome 
III 




a) Improvement with 
defecation 
b) Onset associated with 
changes of stool 
frequency 
c) Onset associated with 





    
    
3. No evidence of 
organic causes 
    
 
aR= adult Rome Criteria for IBS; pR = pediatric Rome Criteria 
*frequency not defined in the adult Rome II criteria for IBS, but in the Rome II IBS questionnaire module. 
**duration of symptoms defined as last 3 months in the adult Rome II questionnaire module but as  at least 3 
months during the prior 12 months and not necessarily consecutive months in the adult IBS II criteria.                                                   
*** only stated in the pediatric Rome III Criteria, but also in the adult Rome II and III questionnaire module.  
  
1.2. Prevalence of abdominal pain and IBS  
Abdominal pain is reported to be the most common type of chronic pain among children in 
pre-pubertal age, with prevalence up to 25%.8 The frequency of abdominal pain is described 
as stable from childhood to adolescence, whereas musculoskeletal pain and headache 
increase during adolescence and are the most frequent chronic pain conditions among both 
adolescents26 and  adults.27-30 
IBS is considered to be the most common cause of abdominal pain in both pediatric and 
adult abdominal pain patients.8,31-34 The prevalence of IBS in adults ranges from 2% to 25% in 
Western countries,32 and some studies have demonstrated an increasing incidence of 
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FGIDs.35 However, comparing previous epidemiological IBS studies is difficult due to different 
classification criteria, which contributes to the inconsistency of IBS prevalence estimates.32,36  
In a Norwegian population-based study, Vandvik et al. found the prevalence of IBS among 
adults to be 8.4 % (Rome II criteria).37   
Hyams et al. found an increasing IBS prevalence from middle to high school students (8% to 
17%), indicating that IBS is less common among younger children than adolescents, but the 
frequency of abdominal pain was similar in both age-groups.33 In a recent study of 
prepubertal children in Germany, the IBS prevalence was 4.9%, but further epidemiological 
pediatric IBS studies are lacking in the Western world. Somewhat higher IBS prevalence 
(about 20%) is reported for adolescents in Asian countries.38,39  
IBS is more common among female adults,11 and abdominal pain is more common among 
adolescent girls.8 Sex- related differences in the prevalence of abdominal pain are less 
consistently found among children before puberty.8   
1.3. Comorbidity in abdominal pain and IBS 
Comorbid chronic pain disorders are prevalent in patients with IBS, with fibromyalgia 
reported to be one of the most frequent (26% to 65%).40 In a systematic review, psychiatric 
illness—mainly anxiety, depression and somatization disorders—is reported to be common 
among patients with IBS (54% to 94%).41 Many of the studies examined severe patients with 
IBS seen in hospitals or outpatient clinics, and it is therefore questionable if these results are 
representative for most patients with IBS, who are never seen by a specialist. Still, a 
population-based Norwegian study by Vandvik et al. found both negative mood symptoms 
and multiple musculoskeletal pain to be more common in IBS than in controls (25% vs. 9% 
and 20% vs. 7% respectively).37 Less is known about the strength of these associations 
among pediatric patients with IBS, but several studies of children with recurrent abdominal 
pain described increased prevalence of psychological and behavioral problems.42-45  
The difference mentioned above in psychiatric comorbidity between patients with IBS and 
what is reported in population-based IBS studies may indicate that the somatic symptom 
burden is dose-dependently associated with the negative mood symptoms. Further, how the 
multiple somatic and psychiatric symptoms in IBS are related remains incompletely 
understood. A few studies of adult patients with FGIDs have shown an association of the 
number co-existing FGIDs and the abdominal pain intensity with degree anxiety and 
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depression.46,47  Negative mood symptoms in IBS and other FGIDs therefore seem to be 
associated with the somatic symptom load in these patients. The significance of comorbid 
pain in this association is to our knowledge unclear. But there are some reports of an 
association between the number chronic pain sites and anxiety and depression among 
individuals with chronic pain in general.48,49  We could for the same reason anticipate that 
the distribution of chronic pain is also related to anxiety and depression among individuals 
with IBS, but the literature provides no evidence for this interpretation. Further, how the 
different and specific abdominal pain dimensions and bowel symptoms in IBS are associated 
with negative mood is to our knowledge not fully understood. Hypothetically, both the 
specific bowel symptoms in IBS and the different abdominal pain dimensions (e.g., 
abdominal pain intensity, distribution, frequency, and duration) may be stressors triggering 
anxiety and depression symptoms.  
1.4. The impact of abdominal pain and IBS 
Reduced quality of life in patients with IBS compared to healthy individuals is reported in 
several studies, as are also increased use of healthcare services and impairments in daily life 
in both adult and pediatric patients with IBS.43,50-52  These associations are also reported to 
be related to degree gastrointestinal symptoms, comorbid somatic symptoms, and 
psychological factors in patients with IBS. Abdominal pain is reported to be the most 
frequent chronic pain causing school absence among children and adolescents.50 In the same 
study, pain intensity, rather than duration and frequency, was the most important pain 
feature affecting quality of life among the children and adolescents.   
Also, health-related costs of IBS are reported to be related to comorbidity in IBS but also to 
the severity of IBS symptoms.53,54 
1.5. Pathophysiological mechanisms of abdominal pain and IBS 
1.5.1. The brain-gut model 
FGIDs are by definition characterized by the absence of evidence of structural, metabolic, or 
biochemical abnormalities in routine clinical diagnostics. This does not necessarily exclude 
possible organic causes but simply reflects the fact that such factors are not detectable with 
currently available clinical diagnostic tools. There is increasing evidence that in at least 
subgroups of patients with IBS, the disorder has an organic etiology, although this is still 
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somewhat controversial. One example is the subset of patients with IBS with reduced 
tolerance to poorly absorbed carbohydrates, such as fructose, lactose, galactans, and 
fructans,55 which is possibly related to alterations of the bacterial gut flora.56 Alterations of 
the gut flora, primarily colonic flora, may be post-infectious after a resolved acute 
gastroenteritis.57,58  The mechanisms are still incompletely understood, and some 
researchers claim that preexisting psychological characteristics are important in the 
development of post-infectious IBS.59,60 This exemplifies the complex interplay between 
psychological and biological factors and central nervous system and local gut factors, in what 
has become known as the brain-gut model in IBS.  Overall, there is increasing evidence of a 
brain-gut model in IBS and other FGIDs, where biological, psychological, and social factors 
contribute and interact in triggering and maintaining the different abdominal and bowel 
symptoms.14,16,61-63  The brain-gut model illustrated in Figure 1 describes plausible peripheral 
and central mechanisms in IBS and the communicating pathways. Whereas some factors and 
mechanisms are most likely to be present in abdominal pain patients in general, others are 
more specific to IBS.13,14,34 
 
 
Figure 1 The brain-gut model in IBS. 
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1.5.2. Increased pain sensitivity and pain sensitization mechanisms 
Visceral hyperalgesia is found to be a “diagnostic marker” of IBS, with high sensitivity and 
specificity.64 Still, increased visceral sensitivity is not evident in all patients with IBS 
compared to healthy controls and has yet not become a routine clinical diagnostic tool.  
Visceral hypersensitivity is manifested as lowered visceral pain thresholds and increased pain 
intensity in response to balloon extension of the rectum.64   The degree of visceral 
hypersensitivity is found to be related to the severity of IBS symptoms65 and also to 
comorbid psychological factors.66  Whether visceral hyperalgesia is a local gut phenomenon 
or is related to mechanisms in the central nervous system is debatable. Some IBS studies 
have found evidence of increased pain sensitivity in other tissues and in body areas other 
than in the visceral organs,67 but whether or not this is related to comorbid chronic pain 
conditions in IBS remains unclear.68,69 To what degree widespread hypersensitivity in IBS is 
related to psychological factors or is independently related to the primary condition is also 
not fully understood.70,71   
Less is known about the relationship between pain sensitivity and IBS and other FGIDs 
among children and adolescents. Some studies of children with AP and IBS have 
demonstrated increased visceral pain sensitivity comparable to that found in adult 
patients.72-74 Little is known about widespread pain sensitivity among pediatric patients, and 
the results of the few studies of children with RAP are somewhat conflicting.75-78   
Pain sensitivity is the relationship between the intensity of a noxious stimulus and 
experienced pain, and it reflects the “gain” of the entire nociceptive processing system. This 
relationship can be quantified by applying well controlled experimental pain stimuli and 
observing the individual’s pain response (i.e., pain rating).  As for pain in general, there is 
great inter-individual variation of measured pain sensitivity and stimuli that lies well beyond 
the tolerance limit of some individuals and may lie well below pain threshold of others.79 
Pain sensitivity is dependent on demographic factors (e.g. sex, age, and ethnicity), 
psychological factors, and as discussed below, it is associated with chronic pain symptoms.80  
Pain sensitivity is poorly correlated across different pain modalities (e.g., heat and pressure 
pain).81 This lack of correlation cannot be dismissed as mere measurement error, since the 
reliability of experimental pain sensitivity tests is generally high.82-84 Thus, it would seem that 
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pain sensitivity is modality specific, which raises the question of which modalities are 
relevant to which types of clinical pain. 
How chronic pain, pain sensitization, and hyperalgesia are related is still not fully 
understood. Pain sensitization is believed to be a consequence of repeated and sustained 
pain sensations, for which there is some evidence from animal models and from 
experimental pain sensitivity research with human volunteers.85,86 There is less clinical 
evidence for these theories, but some studies have shown that increased pain sensitivity also 
predicts higher levels of post-operative acute pain and chronic pain.87 The causal directions 
still remain unclear; possibly the relationships are bidirectional and/or there are shared 
pathophysiological mechanisms.  Figure 2 below shows an hypothetical model of possible 
relationships between chronic pain, pain sensitization, and increased pain sensitivity. 
 
 
Figure 2 Possible relationships between chronic pain, pain sensitization, and increased pain 
sensitivity. 
 
Reduced pain inhibition and /or increased pain augmentation in IBS has been reported at 
different anatomical levels of the nervous system: in the peripheral afferent nerve fibers, 
spinal and supra-spinal levels in the central nervous system, and in addition the autonomic 
nervous system.61,88 
Intestinal immune activation and increased intestinal permeability is described in IBS and 
possibly leads to persistent peripheral neural input and peripheral sensitization.62 There is 






Chronic  pain 
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extremities compared to upper extremities.89 Further, local rectal anesthesia has been 
shown to reduce not only visceral but also somatic pain sensitivity in the lower extremities in 
patients with IBS, whereas similar effects not were seen in healthy controls.90 This supports 
theories of spinal pain sensitization in IBS but does not rule out the importance of supra 
spinal mechanisms.   
The endogenous pain modulation system is found to be influenced by activity in the 
autonomic nervous system, neuroendocrine system, and neuroimmune interactions.61,62,88 
Altered autonomic reactivity has been reported in a subset of patients with IBS during 
symptom flares, with changes in both sympathetic and parasympathetic tones that affect 
the enteric nervous system and gut motility.91,92 Vagal stimulation may attenuate pain both 
centrally and peripherally,93 while efferent sympathetic fibers participate in immune 
activation in the gut.94  Corticotropin-releasing hormone, produced in the hypothalamus, has 
a key role in the response to stress and pain in addition to inhibiting gastric emptying and 
stimulating colonic motor function.95 
Supra-spinal modulation of pain is a dynamic balance between inhibition and facilitation 
mechanisms, located in the brainstem and higher pain centers.85,88 Central pain processing 
communicates neuroanatomical bidirectionally with cognitive, emotional, and autonomic 
brain areas.61 Central pain processing is complex; we have increasing knowledge of which 
brain areas are involved, but the physiological mechanisms are still not fully understood.  
As described above, increased visceral and somatic pain hypersensitivity in patients with IBS 
has been studied employing simple experimental stimulus paradigms. However, these 
paradigms reveal little about the actual mechanisms contributing to hypersensitivity. Several 
dynamic experimental pain methods have been developed to explore the endogenous pain 
modulation processes. Pain sensitization is revealed by repetitive painful stimuli, referred to 
as temporal summation of pain. As compared to healthy controls, increased temporal 
summation of pain has been found in several chronic pain patient groups, such as in persons 
with fibromyalgia.96   An intensely painful stimulus like in the Cold-pressor test has been 
shown to reduce pain applied at other body sites (= conditioned pain modulation). In 
experimental pain studies, conditioned pain stimulation has shown that patients with IBS 
have reduced endogenous pain inhibition or increased pain facilitation compared to healthy 
individuals.77,97  The increasing number studies of FGIDs patients that combine experimental 
pain with functional brain imaging are providing new insights and a better understanding.98  
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Primarily quantitative differences in activity levels in brain areas are seen in IBS as compared 
to healthy individuals.99  
Despite the increasing number studies of pain sensitivity and pain modulation in IBS and to 
some degree in other FGIDs, most of the studies are small, and none have been conducted in 
representative population-based samples. Furthermore, a majority of the studies were 
limited to premenopausal female patients.  It is therefore questionable whether these 
patients are representative for most individuals with IBS symptoms, many of whom never 
seek healthcare for their abdominal symptoms11,100 and others are seen only in primary 
care.101,102 Studies have shown that the majority of IBS patents are followed by their family 
doctors and not by gastroenterologists.11 Further, the extent to which previous results are 
representative for males, older persons, and children and adolescents with IBS symptoms is 
uncertain.   
1.5.3. Local gut mechanisms  
As discussed above, there  is evidence of  local gut mechanisms of IBS.15  Increased intestinal 
permeability, sub-clinical inflammation, and altered gut flora are possible local factors that 
contribute to triggering and maintaining IBS symptoms.103,104 These local factors may also 
contribute to intestinal and colonic dysmotility in IBS.12 Further, they are thought to be 
associated with systemic mechanisms through immunological processes and via the 
peripheral and central nervous system.62 There are still gaps in our knowledge of how the 
peripheral gut factors and the central nervous mechanisms in the brain –gut axis are 
connected in IBS. For instance, the importance of peripheral gut factors in visceral 
hyperalgesia versus sensitization mechanisms in the central nervous system is not fully 
understood.   
Subsets of patients with IBS have reduced tolerance for fermentable carbohydrates. 
Increasing evidence shows that a subset of patients with IBS improve by eliminating or 
restricting dietary intake of fermentable oligo-di-mono-saccharides and polyols (FODMAPs); 
a low FODMAP diet may reduce both abdominal pain and the associated IBS bowel 
symptoms.55,105 
Other local factors are related primarily to bowel movement symptoms in IBS rather than to 
abdominal pain symptoms. Some of the patients with diarrhea-predominant IBS have been 
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found to have increased levels of malabsorbed bile acids in the colon.106 High levels of 
colonic bile acids are thought to be a contributing cause of diarrhea in this subset of patients 
with IBS.  Elevated levels of enteroendocrine production of serotonin are also reported 
among subsets of patients with IBS with prominent diarrheal symptoms.15,107 
1.5.4. Psychosocial mechanisms  
As mentioned above, IBS and AP are strongly associated with a number of psychosocial 
comorbidities. Anxiety, depression, and somatization are the most common psychiatric 
comorbidities.  Some researchers consider these factors to be predictors of abdominal pain 
and IBS,108-110 but it is debatable whether the relationships are causal, and if so, what the 
direction of the causation is. Although some longitudinal cohort studies have been 
conducted, causal interpretations are often difficult to make due to limitations in study 
design. Overall, the possible causal relationships are debatable and to what degree the 
symptoms have shared pathophysiological mechanisms is still not fully understood.14,63 
Therefore, a dualistic psychosomatic understanding of IBS as having a primarily psychiatric 
origin is being increasingly replaced by the biopsychosocial brain-gut model described above.   
Adverse events in early life, such as child abuse, have been cited as possible predictors of 
abdominal pain and IBS later in life,111,112 but as supporting evidence comes from cross-
sectional studies, where results may be affected by recall bias, the results are inconclusive. 
Contradictory evidence comes from another large longitudinal cohort study, where adverse 
childhood events were not found to predict IBS later in life, whereas psychopathology was 
found to be a significant predictor of IBS.109 Similar findings are reported in other studies, 
and for other psychological factors, such as somatization.110  
Some researchers believe that parental factors, including parental psychological and physical 
illness, are predictors of childhood abdominal pain and IBS.113-115  Again, the results of most 
of these studies can only be interpreted as associations and not as clear etiological 
relationships, due to limitations in the study design.  
1.5.5. Heritability of IBS and abdominal pain 
Several studies have also found familial aggregation of abdominal pain and IBS, possibly 
indicating that both environmental and genetic factors are of importance.116,117  The 
magnitude of the heritability is considered moderate, as reported in a systemic review of  
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chronic pain twin-studies.118 Further, an increasing number of candidate genes have been 
found in a subset of patients with IBS. More than 60 genes have been hypothesized to 
genetically predispose to IBS, but their clinical importance is still unclear.119 Molecular-
biological studies of IBS are difficult for several reasons. Identifying candidate genes is 
problematic due to the heterogeneity of the IBS phenotype, but specific gene variants are 
found in  subsets of patients with IBS, such as  gene variants linked to immunological 
processes of the gut in some patients and gene variants linked to serotonin signaling in the 


























2. STUDY QUESTIONS AND AIMS  
There is still conflicting data regarding the presence of widespread hyperalgesia in IBS. 
Specifically, it is not clear whether this association is independent of comorbid chronic pain 
and psychological distress symptoms. Furthermore, the available evidence is based on 
clinical convenience samples, and it is not known whether the findings are valid for the 
general adult and adolescent population.  
 
 The main aim of the study was therefore to compare measured pain sensitivity 
among individuals with and without IBS symptoms in representative adult and 
adolescent samples drawn from the general population, controlling for 
differences in prevalence of comorbid chronic pain and psychological distress 
(Papers 1 & 2 in this dissertation). 
 
It is well established that IBS is strongly associated with depression and other forms of 
negative affect. However, it is not known what specific pain dimensions (e.g., pain 
distribution, duration, intensity, and frequency) are of importance in this association. 
Furthermore, it is not known whether the bowel habits that distinguish IBS from abdominal 
pain in general are associated with negative affect independently of abdominal pain. 
 
 The second aim was therefore to describe how different abdominal pain 
dimensions and associated bowel habits were associated with depression among 







3. MATERIALS AND METHODS 
3.1. Sample 
The Tromsø Study was initiated in 1974 to identify risk factors of cardiovascular diseases, 
which were high-prevalent in this area of Norway. Over time the Tromsø Study was 
expanded to include a wide range of projects related to other lifestyle-associated diseases 
and common health problems in the population. Since the start, six study-waves have been 
conducted with adults in the municipality of Tromsø.  The study is longitudinal and follows 
adults participating in more than one wave as well as new invited participants in each 
subsequent study wave.   
The last adult study was conducted in 2007-2008 (the sixth wave). Of the 19,762 adults 
invited to participate, 66% attended (n = 12 682, median age 58 years (range, 30-87 years) 
and 53.4% women). The sample was a combination of cohorts from previous study waves 
and newly invited adults (Jacobsen et al.120 ). The participants were asked to fill out a health 
questionnaire and to participate in extensive examinations, with medical and physical 
measurements that also included measurements of pain sensitivity (see flow chart of the 
study, below).  
In 2010-2011 the Tromsø Study was expanded to include all adolescents enrolled in the first 
year of high school (this part of the Tromsø Study was named Fit Futures). Students in both 
academic and vocational student programs at all five high schools in the study area 
participated (n = 1,117, with 92.9% response rate n = 1038). The median age of the 
participating students was 16 years (range, 15-28 years), and 48.9% were girls. Students 










Figure 3 Flow chart of the study: Pain sensitivity testing in the adult study 
 
 
Excluded, pre-test: Capacity limitations, technical failure, medical reasons or lack of comprehension.         








508 excluded in screening 
77 excluded pre-test 
79 excluded post-test 
10487 Cold-pressor 
tested 
34 excluded in screening 
227 excluded  pre and post-test 
4054 Heat pain 
tested 
  Second part of study 
118 excluded in screening 
117 excluded post-test 
4689 Pressure pain 
tested 
First part of study 
1831 not examined due to 
capacity limitations 
 6810 non-attandents 
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9 refused all tests 
77 excluded  





3.2. Informed consent 
Both the 6th wave of the Tromsø Study and the Fit Futures Study were approved by the 
Norwegian Social Science Data Services and the Regional Committee for Medical and Health 
Research Ethics, Health Region North. All participants gave their written informed consent 
before inclusion in the study. For participants younger than 16 years, additional consent was 
given by the parent. 
3.3. Questionnaire-based measurements and case definitions 
The questionnaires in the adult study were paper-based, whereas the adolescents in the Fit 
Futures study filled out the health questionnaire electronically, using study-laptops.  
Self-reported symptoms were recorded in the study questionnaires. Self-reported diagnoses 
were not included, and no clinical diagnostics were conducted to confirm the symptom-
based cases as described below.  
3.3.1. IBS case definition: Adults 
In a separate part of the questionnaire, participants who had abdominal discomfort or pain 
during the last year reported if they had the symptoms weekly or more frequently. In the 
next follow-up questions they reported whether defecation relieved the abdominal 
discomfort or pain (1) and if the abdominal symptoms were related to more frequent or 
seldom bowel movements (2) and to harder or looser stools (3).   
 Adults reporting weekly abdominal pain or discomfort during the last 3 months or more 
combined with two or more associated bowel symptoms (numbered 1 to 3 just above) were 
classified as IBS cases in accordance with the Rome II criteria.121,122  
The participants were asked to rate degree of abdominal pain immediately before the IBS 
module. If they fulfilled the IBS criteria, the degree of abdominal pain in the IBS cases could 
be sub-classified as no, mild, or severe abdominal pain.  
3.3.2. IBS and abdominal pain case definitions: Adolescents 
The adolescent participants were asked in a separate gastrointestinal questionnaire module 
how often they had abdominal discomfort or pain the last 2 months. Participants that 
reported weekly or more frequent symptoms were asked to answer the related follow-up 
questions. In the subsequent questions they were asked to localize the abdominal 
discomfort or pain (above, around and/or below the belly button), how long the abdominal 
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symptoms normally last (1-2 hours, 3-4 hours, most of the day, or all the time), for how long 
the symptoms had lasted (1 month or less, 2 months, 3 months, 4-11 months, or one year or 
longer). They were then asked to report the average intensity of their abdominal pain, rated 
on a numeric rating scale (NRS) from 0-10, where 0 = no pain and 10 = the most intense pain 
imaginable.   
Adolescent participants who reported abdominal discomfort or pain were then asked to 
report if the symptoms were related to the following bowel symptoms with a frequency of 
never/rarely, sometimes, or usually: if the discomfort or pain got better after defecation (1) 
and if the symptoms were related to more frequent or seldom bowel movements (2) and to 
harder or looser stools (3).   
Adolescents were classified as IBS cases in accordance with the pediatric IBS III criteria17  if 
they reported weekly abdominal pain or discomfort during the past 2 or more months and 
with two or more of the associated bowel symptoms at least 25% of the time (sometimes or 
more frequently). The adolescent IBS cases were further sub-classified according to their 
pain ratings as mild (NRS = 1-3), moderate (NRS = 4-6), and severe (NRS = 7-10) (none 
reported NRS = 0). 
The study on abdominal pain dimensions and depression in adolescents (paper 3 in this 
dissertation) used a broad definition of abdominal pain so as to include as many participants 
as possible, enabling further subgroup classification with respect to pain frequency and 
duration and other dimensions of abdominal pain. Therefore, participants reporting 
abdominal pain during the past 2 months that occurred at least once a month were defined 
as abdominal pain cases. 
3.3.3. Comorbid chronic pain case definition 
In both the adult and the adolescent study, chronic pain was assessed by items in a separate 
section of the questionnaires. Participants were classified as having chronic pain if they 
responded ‘yes’ to the question, “Do you have persistent or frequently recurring pain that 
has lasted for 3 months or more?”  
Participants who responded yes to the initial question completed follow-up questions, 
including a checklist of body sites where they experienced pain. Since this broad question 
might include abdominal pain, follow-up questions on pain location were used to identify 
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subjects with non-abdominal chronic pain. Thus, subjects reporting pain lasting 3 months or 
longer at any non-abdominal site (i.e., head, yaw, neck, back, shoulder, arm, hand, hip, leg, 
foot, genitalia, or skin) were classified as having comorbid chronic pain.  
3.3.4. Psychological distress and depression case definitions 
Psychological distress symptoms were assessed with the 10-item version of the Hopkins 
Symptom Check List (HSCL). HSCL is a screening tool for detecting negative mood symptoms 
suited for epidemiological research, also among adolescents, and has been validated against 
clinical diagnostic depression and anxiety tools.49,123-125 Subjects with a mean score of 1.85 or 
higher were classified as having psychological distress. This cut-off has previously been 
shown to have a sensitivity of 89% and specificity of 98% with respect to detecting anxiety or 
depression compared to the more extensive 25-item version of the HSCL.126 If data were 
missing for less than four of 10 questions, missing values were replaced by the mean score 
of the remaining answers; otherwise, the HSCL score was set to missing. 
In the adolescent study additional assessment of depression was made with the Short Mood 
and Feeling Questionnaire (SMFQ). SMFQ is a 13-item screening tool for depression that has 
been validated in both clinical samples and in the general population.127,128  SMFQ sum 
scores ≥ 11 have a sensitivity of 86% and specificity of 87% for detecting clinical depression 
in adolescents.129  Consequently, participants scoring above this cut-off were operationally 
defined as cases with depression.  
3.4. Measurements of pain sensitivity 
The study flowcharts and in the Table 2 below provide an overview of enrollment in the 
different pain sensitivity tests in the adult and adolescent studies. The testing was conducted 
by a trained nurse, using a data-assisted protocol. Prior to each test, the test procedure was 
described, and the instructions for threshold, tolerance, and pain intensity rating responses 
were given as appropriate for each test (see  below). Pain intensity ratings in the adult study 
were given on a 0 to 10 numeric rating scale (NRS), with the anchors “no pain” and “the 
most intense pain imaginable.”  Since the participants’ hands were occupied during the 
testing, participants made their ratings by calling out a number from 0 to 10. In the 
adolescent study, pain intensity ratings were given on a computerized visual analog scale 
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(VAS) controlled by a large trackball, with the same anchors as for the NRS.  Instructions for 
use of these scales were adapted from Price et al.130 
In the adult study, participants were asked to complete tests of pain sensitivity, which 
included the cold-pressor test and either pressure pain threshold (first half of study) or heat 
pain threshold (second half of the study). In the adolescent study, all the participants were 
tested in following order; heat, pressure and cold-pressor pain sensitivity measurements. 
Table 2 Overview of the Pain Sensitivity Testing 
 
Pain modality  Body site Adults n Adolescents n 
Cold-pressor     10487  939 
  Hand + wrist     
 Endurance  X  X  
 Pain ratings  X  -  
Heat     4054  929 
  Underarm     
 Threshold  X  X  
 Tolerance  _  X  
Pressure    4689  864 
  Finger  X  X  
  Shoulder  _  X  
 Threshold  _  X  
 Supra-threshold  X  _  
 Tolerance  _  X  
 
n = number of valid tests included in the statistical analyses 
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3.4.1. Cold-pressor test 
Cold-pressor pain was induced using a 3°C water bath (Julabo PF40-HE, JULABO Labortechnik 
GmbH, Germany) connected to a 13 L external plexiglass container with a flow of 22 L/Min. 
The participants submerged their left hand and wrist in the cold water in the plexiglass 
container as long as they were able to, up to maximum 105 seconds. Time to withdrawal of 
the hand was recorded (tolerance limit).  
In the adult study, NRS pain intensity ratings were obtained 4 seconds after the beginning of 
the test and every 9 seconds thereafter until hand withdrawal. In the adolescent study, VAS 
pain intensity ratings were obtained in a similar way, but as these data were not analyzed in 
the papers included in this dissertation, the details are omitted.  
3.4.2. Heat pain tests 
Heat-pain threshold and tolerance (adolescents only) were tested using a MEDOC ATS 
somatosensory stimulator (MEDOC Ltd, Israel) with a 30x30 mm thermode. Stimuli were 
applied to the volar surface of the right forearm. Stimulation started from a baseline 
temperature of 32.0°C and increased by 1°C/s, with an upper safety limit of 50.0°C. For pain 
threshold measurements, participants were instructed to press a button when the sensation 
changed from warmth to pain. Upon pressing the button, the temperature was registered 
and the thermode temperature returned to baseline at a rate of 8°C/s. This procedure was 
repeated three times; the first measurement was discarded and second and third measures 
were averaged. In the adolescent study, threshold measurement was followed by 
assessment of pain tolerance.  Using the same stimulus parameters, participants were asked 
to press the button at the maximum tolerable pain level; they were informed about the 
preset safety-limit at 50.0°C. Heat pain tolerance was measured twice, and the highest 
temperature was recorded. 
3.4.3. Pressure pain tests 
Pressure pain threshold and tolerance (adolescents only) were tested using a hand-held 
algometer (Somedic AB, Sweden) with a circular probe of 1 cm2. Starting at 0 kPa, pressure 
was increased by 30 kPa/s. 
 Among the adolescents, pressure-pain threshold and tolerance were recorded with the 
adolescent pressing a button when the sensation changed from non-painful pressure to pain 
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and at a maximum tolerable pain level, respectively ( limit of 1000 kPa). Pressure was 
applied to the cuticle of the ring finger nail of the right hand and on the midline of the right 
trapezius muscle and in shoulder height. The threshold measurements procedure was 
repeated three times, followed by tolerance measurements, repeated twice. For each site, 
the second and third threshold measure was averaged, and the highest tolerance 
measurements were recorded. 
In the adult study, only the finger site test was conducted with measurements of supra-
pressure pain thresholds. The participants were instructed to press a button when pain 
intensity reached NRS = 5, upon which the pressure was stopped. Starting at 0 kPa, pressure 
was increased by 30 kPa/s up to a maximum of 800 kPa. As with the adolescents, the 
procedure was repeated three times for each subject, and the average of the last two 
measurements was used in the analysis.   
3.5. Statistical analyses 
The statistical methods are described in each separate paper (papers 1, 2, and 3 in this 
dissertation), but the main statistical methods are listed below. The analyses were done 
using SPPS version 18-21. Results are reported with 95% confidence intervals, and results 












Table 3 Overview of the Statistical Analyses 
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ANOVA = analyses of variance, ANCOVA = analyses of co-variance. SMFQ = Short Mood and Feeling 
Questionnaire.  
The Cox regression model was chosen to analyze all pain tolerance results in paper 1 and 
paper 2 because of the relative high number of individuals that did not have tolerance levels 
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below the preset maximum test limit (105 s in the cold-pressor test, 50.0°C in the heat pain 
test, and 1000 kPa in the pressure pain tolerance test). The same approach was applied to 
analyze the supra-threshold levels in the pressure pain test with the adult participants (limit 
at 800 kPa).  
 In paper 1, sex, age, comorbid chronic pain, and psychological distress were entered as co-
factors in the analyses of pain sensitivity in IBS and in the analysis of IBS pain subgroups 
versus controls. Since age was non-linearly related to pain sensitivity, age was categorized in 
four age groups (30-49, 50-59, 60-69, and 70-87 years). In the stepwise analyses (Cox 
regression, analysis of variance) age and sex were included as co-factors in the first step. In 
the second step comorbid chronic pain and psychological distress were added. 
In paper 2, the same statistical approaches were conducted as described in paper 1, but age 
was not included as a co-variable, since there was virtually no variance in age variability 
among the adolescents (15-17 years old), and no differences in mean age between  IBS and 
control groups.  
In paper 3, associations between depression and IBS and abdominal pain were analyzed 
using stepwise logistic regression, adjusting for differences in sex, parental educational level 
(< college or ≥ college), and comorbid chronic pain in the second step. Finally, analysis of 
associations between depression and abdominal pain dimensions were performed for 
individuals with abdominal pain only. This analysis was performed in two steps: First, the 
relationship between depression and each symptom dimension was tested individually, 
using logistic regression and controlling for sex. Next, all symptom dimensions that were 
statistically significant in the first analysis were entered in a multivariate logistic regression. 








4. SUMMARY OF THE RESULTS 
4.1. Paper 1 
 Among the adults, 5.3% reported IBS symptoms (Rome II criteria). 
 Adults with IBS had lower heat pain thresholds, lower cold-pressor pain tolerance, 
and higher pain ratings in the cold-pressor test compared to controls. 
 The associations between increased pain sensitivity and IBS were independent of sex, 
age, comorbid chronic pain, and psychological distress symptoms. 
 The associations were related to degree abdominal pain, with the severe abdominal 
pain IBS cases being the most pain sensitive. The associations were also found to be 
independent of the co-factors listed above. 
 There was no significant difference in the pressure pain thresholds between IBS cases 
and controls. 
4.2. Paper 2 
 Among the adolescents, 8.2% reported IBS symptoms (Rome III criteria). 
 Adolescents with IBS had lower heat pain thresholds and pressure pain thresholds in 
two body sites than controls. 
 The associations between pain thresholds and IBS were independent of sex and 
comorbid chronic pain, but only heat pain and the overall pain threshold sum score 
were significant after further adjustment for psychological distress.  
 The associations were related to degree of abdominal pain in the heat pain threshold 
test and the overall pain threshold sum score, with severe abdominal pain IBS cases 
being the most sensitive. The associations were also found to be independent of the 
co-factors listed above. 
 There was no pain tolerance difference between IBS cases and controls. 
4.3. Paper 3 
 Among the adolescents, 27% (n = 259 of 961) reported abdominal pain monthly or 
more often, and 30% of these (n = 77) fulfilled the IBS Rome III criteria.  
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 The prevalence of depression was 20.5% among adolescents with abdominal pain 
compared to 10.5% in controls. 
 The odds of depression were similar for abdominal pain and IBS cases compared to 
controls (OR = 2.5 vs. 2.4 respectively), after adjustments for sex, comorbid chronic 
pain, and level of parental education.  
 In the multivariable regression analyses within the abdominal pain group, the 
following symptom dimensions were independently associated with depression: 
severe abdominal pain intensity, widespread abdominal pain, and presence of 
comorbid chronic pain. 
 Sex, parental education, and other abdominal pain symptom dimensions, including 
bowel symptoms that distinguish IBS from abdominal pain, were not independently 

















5.1. General discussion: Biopsychosocial understanding of IBS and abdominal pain 
We have in this work demonstrated that individuals with symptoms of IBS have increased 
widespread pain sensitivity (paper 1 and 2). Furthermore, we have found that degree 
abdominal pain, diffuse abdominal and widespread pain distribution are important pain 
dimensions in the association with depression among adolescents with abdominal pain 
(paper 3).  All these results fit in to a biopsychosocial understanding of both IBS and AP, with 
chronic abdominal pain symptoms associated with both widespread hyperalgesia and 
negative affective symptoms.  
Finding widespread pain sensitivity indicates that central nervous mechanisms are of 
importance in IBS, most likely in addition to the peripheral mechanisms as discussed in the 
introduction above. Our findings not only strengthen previous reports on widespread pain 
sensitivity in patients with IBS but also are importantly more generalizable due to the 
population-based study design.  
Clearly, interpretations concerning causality are inappropriate in our project. Most likely the 
relationships among chronic pain symptoms, increased pain sensitivity, and negative 
affective symptoms are multidirectional, possibly with shared pathophysiological 
mechanisms. As described in the introduction above, many researchers believe that pain 
sensitization and increased pain sensitivity are consequences of chronic pain rather than 
causes, although there is also evidence of the opposite. Laboratory-based experiments on 
long-term or repeated pain stimulation of afferents (long-term potentiation and temporal 
summation studies) suggest possible mechanisms whereby persistent pain may lead  to pain 
sensitization.85 The fact that hyperalgesia predicts increased post-operative pain and 
development of post-operative chronic pain supports the opposite theory.87 Further 
evidence is provided by a large prospective study where several measures of pain sensitivity 
were found to be associated with greater incidence of chronic temporomandibular joint 
pain.131 As far as we know, there are no other comparable prospective studies that include 
pain sensitivity assessments and record chronic pain conditions other than 
temporomandibular joint pain.  Therefore, the temporal relationships between chronic pain 
(including IBS and abdominal pain) and increased pain sensitivity are mostly unknown, 
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making causal inferences uncertain.  Finally, the importance of psychological factors such as 
anxiety and depression in the association between IBS and pain sensitivity is still unclear13,132 
, but possible relationships are illustrated in Figure 5 below and discussed further in the next 




Figure 5 Possible relationships between chronic pain in IBS, psychological distress, and pain sensitivity. 
Hyperalgesia may hypothetically trigger and maintain chronic pain symptoms, as illustrated by the lower 
positive feedback arrow.  
As discussed in the introduction of this thesis, there is evidence that several factors 
contribute to triggering and maintaining IBS symptoms rather than a single cause (the 
biopsychosocial model).  None of these factors can be interpreted as causal factors in a strict 
sense, because none are mandatory. There is also no well-documented temporal 
relationship between the factors and IBS.  Although the biopsychosocial model of IBS and 
FGIDs is highly adopted,13,14,34,61,63 there are controversies concerning the importance of the 
different factors in the model as well the question as to whether the factors are independent 
of each other.    
Psychological distress 
 (anxiety and depression)  
Pain 
sensitization 
and  increased 
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In the following sections, our study results will be discussed in the context of understanding 
IBS as a multifactorial condition, including the importance of increased pain sensitivity, 
comorbid chronic pain, and psychological distress and will outline how our findings 
contribute to previous research in this field.   
5.2. Increased widespread pain sensitivity in IBS 
All previous studies of pain sensitivity have been conducted with IBS patients recruited in 
hospitals or in specialized out-patient clinics.67,89,133,134   The majority of studies included only 
premenopausal female patients with IBS. Furthermore, there is to our knowledge only one 
published pediatric IBS study on widespread pain sensitivity in a sample premenarchal girls, 
including 21 case and  an equal number of controls.77 
Overall, a majority of the studies with adults report evidence of widespread pain in patients 
with IBS,67,69,97,132,135,136 whereas this was not found in the single pediatric study77 and in one 
adult study.133 The question is whether these results are representative and valid for the vast 
majority of individuals with IBS symptoms. A larger proportion of individuals with IBS 
symptoms never seek health care for their abdominal complaints.11,100  Furthermore, the 
majority of patients with IBS that are seen by general practitioners have fewer IBS symptoms 
and less comorbidity than patients referred to specialist clinics.101 Consequently, there is a 
risk of selection bias in previous studies, with the milder IBS cases not selected and not 
participating.  
 In contrast to in these case-control studies, we have documented increased pain sensitivity 
among individuals with IBS symptoms in large, representative samples drawn from the 
general population, including both sexes, adults and adolescents, and IBS cases with both 
mild and severe symptoms. Therefore, our study results, which are largely in line with 
previous findings, not only strengthen existing evidence of increased widespread pain 
sensitivity in IBS but also support generalization to a wider spectrum of individuals with IBS 
symptoms.    
To what degree widespread hyperalgesia in IBS is a result of confounding with comorbid 
chronic pain conditions is unclear. This issue is of some importance, as increased pain 
sensitivity has been demonstrated in a number chronic pain conditions, such as fibromyalgia, 
that are common in patients with IBS. Some previous adult studies have included patients 
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with and without comorbid fibromyalgia in addition to healthy controls, with some reporting 
that IBS is independently associated with increased pain sensitivity and others reporting the 
opposite.68,69,133 Due to the large sample sizes in our studies, we could control for 
confounding in the analyses more extensively than has been possible in previous case-
control studies.  
Some researchers have found that hyperalgesia in IBS is found mainly in the lower body 
parts and is to a lesser degree present in the upper body.69,71,85  This finding suggests altered 
pain modulation at peripheral and spinal levels rather than at supraspinal levels in the 
central nervous system.  We found that IBS was independently associated with widespread 
increased pain sensitivity, after controlling for comorbid non-abdominal pain, with all pain 
tests conducted at sites that are remote from the location of clinical pain (finger, arm, and 
shoulder).  Therefore, our results support theories of central pain sensitization mechanisms 
in IBS, at least at higher spinal or supraspinal levels. It is important to emphasize that our 
findings do not rule out the possibility that topographical pain sensitivity differences in IBS 
occur in addition to the widespread hyperaglesia documented in our studies. 
 Our findings are further strengthened by the dose-dependent relationship between degree 
of abdominal pain in IBS and degree of hyperalgesia, a finding that was also significant after 
adjusting for comorbid pain. A small number of previous studies have reported similar dose-
dependent findings.70,136 Furthermore, our results harmonize with previous visceral 
sensitivity studies among patients with IBS that described a dose-dependent relationship 
between degree of IBS symptoms and visceral hyperalgesia.65,137  
The IBS diagnostic criteria require the presence of pain or discomfort, and thus the presence 
of pain is not mandatory. Consequently, 16% of adults but none of the adolescents met the 
IBS criteria while reporting no abdominal pain. Interestingly, our results suggest an absence 
of hyperalgesia among these cases. In view of what appears to be qualitative differences 
between IBS cases reporting and not reporting pain, one might question whether the 
diagnostic criteria are too inclusive and whether some degree of pain should be mandatory 
in the diagnostic criteria. 
There is considerable controversy regarding the importance of psychological factors in the 
association between IBS and hyperalgesia. Several studies have found that negative affect is 
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associated with increased pain sensitivity.138 These symptoms are common among patients 
with IBS and could therefore explain why patients with IBS are more pain sensitive than 
healthy controls (i.e., confounding). Some researchers report that the association between 
IBS and widespread hyperalgesia is independent of negative affect, whereas others report 
the opposite.67,69-71,97,133 Conflicting findings are also described in studies of visceral pain 
sensitivity in IBS.65,66,137,139,140  In addition to anxiety and depression, symptoms of 
somatization have been reported to be associated with hyperalgesia in IBS, at least in 
patients with IBS with fibromyalgia.133 Arguments against the latter are discussed in a study 
by Verne et al. , where somatization and hypervigilance  were not found to be associated 
with increased pain sensitivity in IBS.71  Overall, the diverging results from previous case-
control studies are difficult to interpret. Differences in samples and methodological aspects, 
such as diverging measurements of comorbid psychiatric symptoms, complicate 
comparisons. Furthermore, several of the previous studies are limited by small sample sizes, 
which make them statistically vulnerable for type 2 errors.  We found that IBS symptoms 
were independently associated with increased pain sensitivity among adults after controlling 
for psychological distress (HSCL > 1.85).  The large sample sizes suggest that previous studies 
that have failed to find an independent association are false negative results. Similar findings 
were made among adolescents with IBS for heat pain threshold but not for pressure pain 
threshold after adjusting for psychological distress. In paper 2 in this dissertation, the latter 
is discussed as a possible type II error due to the relatively small adolescent IBS sample. It 
should also be noted that we found a convincing trend of lower pain thresholds for all pain 
modalities, in addition to a lower total threshold sum score, in IBS.  
Only a few small studies have examined somatic pain sensitivity in pediatric abdominal pain 
patients, and only a single study examined pediatric patients with IBS. No difference 
between children with recurrent abdominal pain or IBS and controls was found in two of the 
studies that examined pain tolerance.77,141 In line with our findings, two studies 
demonstrated lower pain thresholds in children with abdominal pain than in controls.75,76 
However, Zohsel et al. found no pain threshold differences in children with abdominal pain 
versus controls and argues against generalized hyperalgesia in RAP patients.78 The pediatric 
pain sensitivity studies cited here are not only limited by relative small sample sizes but also 
to a large extent by the lack of measures of comorbid conditions. The importance of both 
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comorbid pain and psychological distress symptoms has therefore not been assessed in 
earlier studies of pain sensitivity in pediatric abdominal pain patients, with the exception of 
one study describing no difference in social and neurotic characteristics between RAP 
children and no-pain patients.75   Our study is the first not only to find an association 
between adolescent IBS and increased pain sensitivity but also, and importantly, to find that 
this association is independent of comorbid pain and psychological distress. Furthermore, 
our results are supported by the dose-dependent relationship between degree of abdominal 
pain in IBS and reduction of the pain thresholds. 
To our knowledge, a possible age-dependent difference in pain sensitivity in IBS is poorly 
described in the literature.  In our studies the difference in heat pain thresholds between IBS 
and controls was comparable for adults and adolescents (- 0.5°C and - 0.8 °C in adult and 
adolescent IBS vs. controls). Similar trends towards lower pressure pain thresholds in IBS 
were found in the two age cohorts, but the results are not directly comparable due to 
different methodology (pain thresholds versus supra-thresholds in adolescents and adults, 
respectively). The pressure pain threshold differences were small and not significantly lower 
in adult IBS than in controls. Our results therefore indicate that IBS hyperalgesia, with lower 
pain thresholds compared to controls, is independent of age. On the other hand, the same 
age pattern was not found in the cold-pressor pain tolerance test. Adult IBS cases had 
significant lower tolerance than controls, which was also found to be dose-dependently 
related to degree abdominal pain in IBS. The same difference was not demonstrated in the 
cold-pressor test among the adolescents, but comparisons are somewhat difficult due to the 
ten-fold difference in sample size. Still, the lack of pain tolerance differences between 
adolescent IBS and controls in the additional test (heat and pressure pain) supports the 
validity of the cold-pressor results.  A comparison of our two samples, therefore, indicates 
that pain tolerance in IBS is age dependent. The reasons for this are not clear. The 
proportion of subjects with comorbid chronic pain and psychological distress were similar for 
adult and adolescent IBS cases compared to controls (approximately two and three times 
higher than among controls, respectively), making it unlikely that these comorbidities 
contribute to age-related differences.  One possibility is that reduced pain tolerance 
develops as a function of pain duration, which is much longer among adults than 
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adolescents. Consequently, but theoretically, adults with IBS are more pain sensitized over 
time. However, this hypothesis will need to be confirmed in prospective studies.  
5.3. IBS prevalence and comorbidity 
The adult IBS prevalence of 5.3% is in the lower range of the prevalence reported by 
previous epidemiological reports.142 It is also lower than Vandvik et al. found in a cross-
sectional population-based study in the Hedemark and Oppland Counties of Norway in 2001 
(8.4%).37 Both studies used the IBS Rome II criteria, but the higher prevalence found by 
Vandvik et al. might be explained by the inclusion of younger adults than in our study (older 
than 20 vs. older than 30 years of age). Our finding of higher prevalence among adolescents 
from the same municipality of Tromsø (8.2%) is a further indication that this may be the 
case, but the IBS criteria differ somewhat in the two studies. The sex and age distribution in 
the study samples is an important issue when evaluating IBS prevalence, with the knowledge 
that prevalence is higher in women than in men32 and decreases with increasing age.32,37  
When comparing IBS prevalence studies is it important to be aware that the IBS criteria have 
changed over time, mainly with respect to IBS symptom duration and frequency. The 
differences are relatively small within the Rome IBS criteria,143 while poorer agreement is to 
be expected with the earlier classification criteria (Manning criteria, which are less restrictive 
compared to the Rome criteria).144  In a previous Tromsø Study from 1979-80 the prevalence 
of irritable colon was 8% in men and 13% in women,145 but these results are not directly 
comparable with the IBS prevalence estimates in our study due to differences in irritable 
colon and IBS definitions.   
There are few population-based pediatric studies of IBS prevalence, but it is reported to 
increase during childhood and adolescence.33 Our estimates were lower than the prevalence 
found in one North American study in  1996 (17%)33 but somewhat higher than in  a more 
recent study of younger children in Germany aged 6 to 10 years (4.9 % ).146 The prevalence 
of IBS is reported to be higher in both a Chinese (19.9%) and Japanese (19%) population-
based adolescent study, using the Rome III and II criteria, respectively.147,148 Again, 
comparing results is difficult due to differences in the IBS criteria and age composition of the 
samples. It is possible that the higher prevalence found in the two Asian studies may reflect 
true cultural and/or ethnic differences, but caveats above make this conclusion uncertain.149  
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The high prevalence of psychological distress (HSCL ≥ 1.85) in adult IBS accords with what is 
described in the medical literature,10,37,150 as is the high rate of comorbid chronic pain.41 
Although there are fewer studies on these issues in children and adolescents with IBS, the 
same pattern of comorbidity has been found in children.8,44,151 In a study by Gulewitsch et 
al., IBS symptoms were associated with increased emotional problems compared to children 
without abdominal pain.146 These children also had increased levels of somatic symptoms 
other than IBS, including non-abdominal pain, in accordance with our findings. To our 
knowledge, only one community-based study of IBS in adolescents has been conducted 
previously. In that study, a higher frequency of anxiety and depression symptoms were 
reported in both children and adolescents with IBS compared to controls.33  A higher 
prevalence of headache was also reported in that study among children and adolescents 
with abdominal pain compared to children without, but the prevalence of headache was not 
specifically reported for the IBS subgroup. Consequently, we have shown that IBS symptoms 
are common among adolescents in the general population and that these individuals have 
an overall greater symptom burden, including higher rates of comorbid pain, anxiety, and 
depression.  
5.4. Abdominal pain symptom dimensions and depression 
Although there are many studies on comorbid psychological problems in children with 
abdominal pain,44,45,146 there is little knowledge about the association of the specific 
abdominal pain symptom dimension with depressive symptoms. Both IBS and recurrent 
abdominal pain symptoms in general were associated with symptoms of depression among 
the adolescents, as described in paper 3 in this dissertation. These findings are in accordance 
with what is described in previous comparable adult and pediatric studies. As described in 
paper 3, the association was strong and only slightly attenuated after controlling for sex, 
parental level of education, and comorbid chronic pain. 
To study how specific pain and bowel symptoms were associated with depression, we 
conducted further investigations within the group of adolescents with recurrent abdominal 
pain (n = 257).  This was done because these symptoms were not measured among pain-free 
individuals, rendering analysis across this group meaningless.  In the subgroup analyses, 
abdominal pain intensity, distribution (number of pain sites), and comorbid chronic pain 
remained the only significant predictors of depression. Remaining pain dimensions, including 
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pain duration and frequency, and bowel symptoms that are mandatory for the IBS diagnosis 
were not significantly associated with depression in the multi-variable analyses.  That 
abdominal pain per se is important in this association, rather than the associated bowel 
symptoms in IBS, is further strengthened by the group analyses within the whole study 
sample, which found comparable odds of depression for IBS (OR 2.4) and abdominal pain 
(OR = 2.5) compared to controls.  To our knowledge there are no similar reports for children 
or adolescents with IBS or abdominal pain, when studying the specific pain dimensions in 
multi-variable models, but some reports have described associations between mental health 
and some of these dimensions individually.33,42,43,45,152  To our knowledge, the association 
between abdominal pain and depression, the strongest association in our model, has not 
been examined previously. Individuals that reported widespread abdominal pain had 5.5 
times higher odds of depression compared to pain in a limited abdominal area (95% CI = 2.6-
11.8). Furthermore, comorbid chronic pain was found to increase the odds of depression in 
the same multiple logistic regression analysis (OR = 3.3 with 95% CI = 1.6-6.8). Hence, the 
pain distribution within and beyond the abdominal region appears to be the strongest 
predictor of depression. Theoretically, a clinical implication could be that multi-site pain is 
less “manageable” than single site pain.  This implies that depression is a consequence of 
chronic pain, but it is a question that remains unclear.  But this interpretation is supported 
by results from a prospective study where the number chronic pain sites were found to 
predict mental stress symptoms later in life in a dose-dependent manner.49 
The association between abdominal pain severity and mental health problems has been 
described in a few adult IBS studies. Heitkemper et al. found that psychological distress in 
IBS is more strongly related to the abdominal pain severity than the predominant stool 
pattern.153 Less is known about this association among children and adolescents with IBS, 
but Hyams et al. found that abdominal pain severity was correlated with both anxiety and 
depression among adolescents with IBS symptoms.33  
 IBS severity and the burden of the disorder was reported by Bond et al. to be associated 
with a combination of the different abdominal and bowel symptoms and to the extra-
intestinal somatic symptoms in IBS.154 In that same study, IBS severity was the most highly 
correlated with the non-bowel symptoms, including abdominal pain symptoms.  Whether or 
not the overall burden of illness is associated with depression or other mental health 
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problems is not addressed in the study. Another study reported that the degree of 
abdominal pain is associated with impairments of physical functioning in IBS but not with 
decreased mental functioning.155   
Clinically and in research, the sub-classification of IBS is primarily based on the bowel 
symptoms (diarrhea- or constipation-prominent type of IBS, or mixed subgroups) rather than 
other abdominal symptoms.9 The high grade of comorbidity is also not part of the 
diagnostics and sub-classification of IBS, which some researchers have criticized.156 The 
heterogeneity of patients with IBS may be at least partly explained by the lack of 
discrimination between abdominal pain and discomfort in the IBS criteria. Studies have 
shown that patients with IBS distinguish these two symptom entities.157  With the knowledge 
that the abdominal pain severity in IBS has a great impact on both mental health and quality 
of life,52,158 it seems reasonable to distinguish non-pain (discomfort) and abdominal pain 
patients.  
5.5. Methodological considerations  
5.5.1. Representativeness 
With the combination of a randomly sampled study population and a participation rate of 
66% in wave 6 of the Tromsø Study, we could anticipate that the study sample was 
representative for the general adult population above age 30 years in the municipality of 
Tromsø, Norway.  As discussed above, we found a relatively low IBS prevalence, which could 
have been a consequence of the somewhat higher proportion older adults (median age 58 
years) in addition to not including individuals below age 30 years. The participation rate in 
the adolescent study was very high (92.4%) and included almost all adolescents in the study 
area that attended the first year of the upper high school, but missing the adolescents that 
were not enrolled or quit before the recruitment reached the specific school of attendance. 
The exact number adolescents not attending or dropping out of first year high school before 
recruitment is unclear. Therefore, IBS prevalence in these cases remains unknown. But 
importantly, the associations of IBS and pain sensitivity, as the associations of abdominal 
pain and depression are most likely not affected by possible under or over estimations of 
abdominal pain and IBS prevalence’s in our study.  
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5.5.2. Misclassification and measurement errors  
As described in the Methods section above, the Rome II and III criteria for IBS were used in 
the adult and adolescent study, respectively. Most validation studies of the IBS criteria are 
on clinical samples, and little is known about how the criteria perform in a population-based 
setting.  The IBS criteria sensitivity is considered moderate to reasonably good, compared to 
clinical IBS diagnostics (0.7-0.9).19,22 Poorer specificity is reported in discriminating IBS from 
organic diseases with similar abdominal and bowel symptoms (about 0.7), but the specificity 
is reported to be better when typical red flag symptoms of organic disease are absent 
(0.9).159 Questions about the presence of red flag symptoms were not included in our study, 
increasing the risk of misclassifying organic gastrointestinal diseases as IBS. But most of 
these diseases are relative uncommon (e.g., celiac disease and inflammatory bowel disease) 
in the general population compared to clinical populations. Furthermore, it is even less likely 
that one these diseases is unrecognized or poorly treated (non-remission). Moreover, having 
an organic bowel disease does not rule out the possibility of simultaneous comorbid IBS.  We 
therefore believe that the classification of the IBS cases in our study is reasonable correct, 
with a relative small proportion of cases having an organic disease that causes their 
abdominal pain and bowel symptoms.   
The HSCL (10-item version) was used to identify participants with psychological distress 
(anxiety and depression symptoms) in papers 1 and 2, and the SMFQ was used in paper 3 to 
identify individuals with depression. Further details on these questionnaires are described in 
the Methods section above. These measurements are developed for screening and are used 
in epidemiological research, but they are not clinical diagnostic tools. As for IBS, there is a 
risk of misclassification, but is reasonable to anticipate equal distribution of misclassification 
in IBS and abdominal pain cases as in controls.   
The within-session reliability of experimental pain assessment is typically found to be high 
(Cronbach’s alpha > 0.9). 160  Information on the long term stability of these measures (i.e. to 
what extent they reflect a stable trait of the individual) is more sparse, but there is at least 
some support for stability over time. 161,162  
 Pain sensitivity assessments are still vulnerable for both procedural and technical errors. 
One of the most important issues was to secure uniform pain sensitivity testing through 
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standardized procedures, including exactly the same instructions to each participant. 
Possible technician-related procedural and technical errors would most likely have a random 
distribution among both the IBS cases and controls and would therefore not affect our study 
results.   
As described in the study flow charts above, participants with comprehension difficulties 
(e.g., dementia) were excluded in screening before testing and further tests were of the 
technicians reported as invalid due to non-comprehension. Still, we cannot exclude less 
evident errors related to how the participants understood the procedural instructions. But 
we believe that this problem was infrequent and, again, that the distribution of possible 
errors is equal in both the IBS and control group.   
5.5.3. Confounding 
Both comorbid pain and psychological distress symptoms are known to be associated with 
both IBS and pain sensitivity. If and to what degree the same symptoms are confounders in 
the association between IBS and increased pain sensitivity is unclear, however, mostly due 
to methodological issues and small sample sizes in previous case-control studies. That we 
found an independent association between IBS and increased pain sensitivity after 
adjustments for comorbid pain and psychological distress does not exclude confounding 
effects. But, as discussed in the papers in this dissertation, the magnitude of IBS as an 
independent predictor was only slightly attenuated after the same adjustments, indicating 
only a small if overall present confounding effect.  
Unnecessary adjustments could also be a consequence when a co-factor is added in the 
analyses, but not fulfilling the confounding factor requirements as mentioned above. If the 
factor is an intermediate factor rather than an independent factor, there is a risk of over-
adjustment errors in the analyses. Likewise if the factor is a consequence rather than a cause 
of the outcome in question. Adjustment errors could also be a consequence in situations 
where the factor is completely out of the system of interest or only associated with either 
the main predictor or outcome. In these situations, adjustments will not necessarily alter the 
magnitude of the crude association but will primarily reduce the precision in the analyses 
(wider confidence interval).  As discussed in paper 2 in this dissertation, psychological 
distress symptoms were not a significant covariate in the analyses of the pressure pain 
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thresholds in IBS and controls. Furthermore, the mean difference between IBS and controls 
was basically unchanged after controlling for psychological distress symptoms, but the 
confidence interval increased, and the differences between IBS and controls turned out to 
be non-significant after the same adjustments. This may therefore be an over-adjustment 
rather than a true confounding effect. As discussed in paper 2, an additional cause may be 
related to the relatively small IBS sample in the adolescent study (type II error). The same 
power problem could also explain the somewhat inconsistent heat pain threshold findings in 
the adult IBS pain subgroups described in paper 1.   
Finally, the independent association between IBS and increased pain sensitivity found does 
not rule out the possibility of residual confounding. In our analyses, as discussed in the 
papers, symptoms of somatization in IBS are a possible residual confounder.  
5.5.4. Incomplete data 
If there were missing data in the IBS module and participants had responded in the prior 
question that they had no abdominal pain during the last year, they were categorized as no-
IBS (= controls). But when missing answers in both the IBS module and the prior 
questionnaire item on chronic abdominal pain they were handled as missing (n = 1621 and 
12.5%).  The relatively high proportion of incomplete IBS data may have affected the IBS 
prevalence estimates and, to a lesser degree, the main analyses of associations between IBS 
and pain sensitivity. Missing answers were somewhat more frequent among both male and 
the older participants, but we did not discover any evident differences between the two 
groups in prevalence of comorbid chronic pain and psychological distress. 
Imputation techniques were not conducted in our studies, but as described above, missing 
HSCL scores were replaced by the mean of the completed answers, which is in accordance 
with procedures followed in other previous studies.126 Participants missing more than three 
of 10 answers were handled as missing (n = 684 and 5.3%).  
 Participants missing physical pain sensitivity measurements were compared with the 
participants that had undergone the testing. This is described in paper 1, with the finding 
that there were no differences in IBS prevalence between these two groups, but the 
participants with missing measurements were somewhat older, more often women, and had 
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more psychological distress than the participated that had the testing. As described in the 
paper, these differences were not significant after controlling for sex and age.  
5.6. Conclusions, implications, and future studies 
The association between IBS and increased widespread pain sensitivity among adolescent 
and adult individuals in the general population, which was found to be independent of 
comorbid pain and psychological distress, is the main and most important finding of our 
project. This finding confirms results from previous clinical case-control studies and expands 
on previous studies by providing grounds for generalizing to the general population. Our 
finding provides strong evidence of CNS involvement in the disorder and central pain 
sensitization mechanisms in IBS.  
Furthermore, we found that diffuse widespread abdominal pain, multi-site chronic pain, and 
abdominal pain intensity were all independently associated with depression. Whether or not 
the same pain dimensions are risk factors for or consequences of depression remains to be 
elucidated in prospective studies, but our results support screening for depression among 
adolescent patients with severe abdominal pain and multi-site pain.   
The strong association between abdominal pain intensity and both hyperalgesia and 
depression support greater attention on abdominal pain per se in IBS. By contrast, pain-free 
IBS and IBS related bowel symptoms were not independently related to these outcomes. 
This suggests that the diagnostic classification of the disorder may be improved by 
distinguishing IBS patients with abdominal pain from those reporting discomfort without 
pain.  
Our study was cross-sectional and therefore unsuited for demonstrating order effects and 
testing hypotheses about causal relationships. The upcoming seventh Tromsø study, where 
all participants in both the adolescent and adult samples will be invited for a repeated 
examination, may contribute in better understanding of the temporal relationships between 







1. Merskey H. The taxonomy of pain. The Medical clinics of North America. Jan 2007;91(1):13-
20, vii. 
2. Stanton TR, Latimer J, Maher CG, Hancock MJ. How do we define the condition 'recurrent 
low back pain'? A systematic review. Eur Spine J. Apr 2010;19(4):533-539. 
3. Stovner LJ. Headache epidemiology: how and why? The journal of headache and pain. Jun 
2006;7(3):141-144. 
4. Phillips K, Clauw DJ. Central pain mechanisms in the rheumatic diseases: future directions. 
Arthritis and rheumatism. Feb 2013;65(2):291-302. 
5. Thompson WG. The road to rome. Gastroenterology. Apr 2006;130(5):1552-1556. 
6. Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the 
irritable bowel. British medical journal. Sep 2 1978;2(6138):653-654. 
7. Apley J, Naish N. Recurrent abdominal pains: a field survey of 1,000 school children. Arch Dis 
Child. Apr 1958;33(168):165-170. 
8. Chitkara DK, Rawat DJ, Talley NJ. The epidemiology of childhood recurrent abdominal pain in 
Western countries: a systematic review. Am.J.Gastroenterol. 2005;100(8):1868-1875. 
9. Drossman DA. The functional gastrointestinal disorders and the Rome III process. 
Gastroenterology. Apr 2006;130(5):1377-1390. 
10. Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA. Migraine, fibromyalgia, and depression 
among people with IBS: a prevalence study. BMC gastroenterology. 2006;6:26. 
11. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable 
bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther. Mar 1 
2003;17(5):643-650. 
12. Gunnarsson J, Simren M. Peripheral factors in the pathophysiology of irritable bowel 
syndrome. Dig.Liver Dis. 2009;41(11):788-793. 
13. Elsenbruch S. Abdominal pain in Irritable Bowel Syndrome: a review of putative 
psychological, neural and neuro-immune mechanisms. Brain Behav.Immun. 2011;25(3):386-
394. 
14. Mayer EA, Tillisch K. The brain-gut axis in abdominal pain syndromes. Annual review of 
medicine. 2011;62:381-396. 
15. Camilleri M. Peripheral mechanisms in irritable bowel syndrome. The New England journal of 
medicine. Oct 25 2012;367(17):1626-1635. 
16. Camilleri M, Di Lorenzo C. Brain-gut axis: from basic understanding to treatment of IBS and 
related disorders. Journal of pediatric gastroenterology and nutrition. Apr 2012;54(4):446-
453. 
17. Rasquin A, Di Lorenzo C, Forbes D, Guiraldes E, Hyams JS, Staiano A, Walker LS. Childhood 
functional gastrointestinal disorders: child/adolescent. Gastroenterology. Apr 
2006;130(5):1527-1537. 
18. Vanner SJ, Depew WT, Paterson WG, DaCosta LR, Groll AG, Simon JB, Djurfeldt M. Predictive 
value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastroenterol. 
Oct 1999;94(10):2912-2917. 
19. Ford AC, Bercik P, Morgan DG, Bolino C, Pintos-Sanchez MI, Moayyedi P. Validation of the 
Rome III Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care. 
Gastroenterology. Aug 28 2013. 
20. Helgeland H, Flagstad G, Grotta J, Vandvik PO, Kristensen H, Markestad T. Diagnosing 
pediatric functional abdominal pain in children (4-15 years old) according to the Rome III 
Criteria: results from a Norwegian prospective study. Journal of pediatric gastroenterology 
and nutrition. Sep 2009;49(3):309-315. 
49 
 
21. Caplan A, Walker L, Rasquin A. Validation of the pediatric Rome II criteria for functional 
gastrointestinal disorders using the questionnaire on pediatric gastrointestinal symptoms. 
J.Pediatr.Gastroenterol.Nutr. 2005;41(3):305-316. 
22. Engsbro AL, Begtrup LM, Kjeldsen J, Larsen PV, de Muckadell OS, Jarbol DE, Bytzer P. Patients 
suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of 
Rome III criteria in primary care. Am J Gastroenterol. Jun 2013;108(6):972-980. 
23. Vandvik PO, Aabakken L, Farup PG. Diagnosing irritable bowel syndrome: poor agreement 
between general practitioners and the Rome II criteria. Scandinavian journal of 
gastroenterology. May 2004;39(5):448-453. 
24. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. 
Functional bowel disorders and functional abdominal pain. Gut. Sep 1999;45 Suppl 2:Ii43-47. 
25. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional 
bowel disorders. Gastroenterology. Apr 2006;130(5):1480-1491. 
26. King S, Chambers CT, Huguet A, MacNevin RC, McGrath PJ, Parker L, MacDonald AJ. The 
epidemiology of chronic pain in children and adolescents revisited: a systematic review. Pain. 
Dec 2011;152(12):2729-2738. 
27. Leadley RM, Armstrong N, Lee YC, Allen A, Kleijnen J. Chronic diseases in the European 
Union: the prevalence and health cost implications of chronic pain. Journal of pain & 
palliative care pharmacotherapy. Dec 2012;26(4):310-325. 
28. van Hecke O, Torrance N, Smith BH. Chronic pain epidemiology and its clinical relevance. 
British journal of anaesthesia. Jul 2013;111(1):13-18. 
29. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: 
prevalence, impact on daily life, and treatment. European journal of pain (London, England). 
May 2006;10(4):287-333. 
30. Reid KJ, Harker J, Bala MM, Truyers C, Kellen E, Bekkering GE, Kleijnen J. Epidemiology of 
chronic non-cancer pain in Europe: narrative review of prevalence, pain treatments and pain 
impact. Current medical research and opinion. Feb 2011;27(2):449-462. 
31. Grundmann O, Yoon SL. Irritable bowel syndrome: epidemiology, diagnosis and treatment: 
an update for health-care practitioners. J Gastroenterol Hepatol. Apr 2010;25(4):691-699. 
32. Quigley EM, Abdel-Hamid H, Barbara G, Bhatia SJ, Boeckxstaens G, De Giorgio R, Delvaux M, 
Drossman DA, Foxx-Orenstein AE, Guarner F, Gwee KA, Harris LA, Hungin AP, Hunt RH, 
Kellow JE, Khalif IL, Kruis W, Lindberg G, Olano C, Moraes-Filho JP, Schiller LR, Schmulson M, 
Simren M, Tzeuton C. A global perspective on irritable bowel syndrome: a consensus 
statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel 
syndrome. Journal of clinical gastroenterology. May-Jun 2012;46(5):356-366. 
33. Hyams JS, Burke G, Davis PM, Rzepski B, Andrulonis PA. Abdominal pain and irritable bowel 
syndrome in adolescents: a community-based study. The Journal of pediatrics. Aug 
1996;129(2):220-226. 
34. Chiou E, Nurko S. Functional abdominal pain and irritable bowel syndrome in children and 
adolescents. Therapy. May 1 2011;8(3):315-331. 
35. Ehlin AG, Montgomery SM, Ekbom A, Pounder RE, Wakefield AJ. Prevalence of 
gastrointestinal diseases in two British national birth cohorts. Gut. Aug 2003;52(8):1117-
1121. 
36. Yale SH, Musana AK, Kieke A, Hayes J, Glurich I, Chyou PH. Applying case definition criteria to 
irritable bowel syndrome. Clinical medicine & research. May 2008;6(1):9-16. 
37. Vandvik PO, Lydersen S, Farup PG. Prevalence, comorbidity and impact of irritable bowel 
syndrome in Norway. Scandinavian journal of gastroenterology. Jun 2006;41(6):650-656. 
38. Zhou H, Li D, Cheng G, Fan J, Lu H. An epidemiologic study of irritable bowel syndrome in 




39. Rajindrajith S, Devanarayana NM. Subtypes and Symptomatology of Irritable Bowel 
Syndrome in Children and Adolescents: A School-based Survey Using Rome III Criteria. 
Journal of neurogastroenterology and motility. Jul 2012;18(3):298-304. 
40. Riedl A, Schmidtmann M, Stengel A, Goebel M, Wisser AS, Klapp BF, Monnikes H. Somatic 
comorbidities of irritable bowel syndrome: a systematic analysis. Journal of psychosomatic 
research. Jun 2008;64(6):573-582. 
41. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel 
syndrome with other disorders: what are the causes and implications? Gastroenterology. Apr 
2002;122(4):1140-1156. 
42. Youssef NN, Atienza K, Langseder AL, Strauss RS. Chronic abdominal pain and depressive 
symptoms: analysis of the national longitudinal study of adolescent health. 
Clin.Gastroenterol.Hepatol. 2008;6(3):329-332. 
43. Saps M, Seshadri R, Sztainberg M, Schaffer G, Marshall BM, Di Lorenzo C. A prospective 
school-based study of abdominal pain and other common somatic complaints in children. 
The Journal of pediatrics. Mar 2009;154(3):322-326. 
44. van der Veek SM, Derkx HH, de Haan E, Benninga MA, Boer F. Abdominal pain in Dutch 
schoolchildren: relations with physical and psychological comorbid complaints in children 
and their parents. Journal of pediatric gastroenterology and nutrition. Oct 2010;51(4):481-
487. 
45. Vila M, Kramer T, Obiols JE, Garralda ME. Abdominal pain in British young people: 
associations, impairment and health care use. Journal of psychosomatic research. Dec 
2012;73(6):437-442. 
46. Bouchoucha M, Hejnar M, Devroede G, Babba T, Bon C, Benamouzig R. Anxiety and 
depression as markers of multiplicity of sites of functional gastrointestinal disorders: A 
gender issue? Clinics and research in hepatology and gastroenterology. Dec 24 2012. 
47. Addolorato G, Mirijello A, D'Angelo C, Leggio L, Ferrulli A, Abenavoli L, Vonghia L, Cardone S, 
Leso V, Cossari A, Capristo E, Gasbarrini G. State and trait anxiety and depression in patients 
affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to 
an internal medicine outpatient setting. International journal of clinical practice. Jul 
2008;62(7):1063-1069. 
48. Bohman H, Jonsson U, Paaren A, von Knorring L, Olsson G, von Knorring AL. Prognostic 
significance of functional somatic symptoms in adolescence: a 15-year community-based 
follow-up study of adolescents with depression compared with healthy peers. BMC 
psychiatry. 2012;12:90. 
49. Lien L, Green K, Thoresen M, Bjertness E. Pain complaints as risk factor for mental distress: a 
three-year follow-up study. European child & adolescent psychiatry. Oct 2011;20(10):509-
516. 
50. Roth-Isigkeit A, Thyen U, Stöven H, Schwarzenberger J, Schmucker P. Pain Among Children 
and Adolescents: Restrictions in Daily Living and Triggering Factors. Pediatrics. February 1, 
2005 2005;115(2):e152-e162. 
51. Varni JW, Lane MM, Burwinkle TM, Fontaine EN, Youssef NN, Schwimmer JB, Pardee PE, Pohl 
JF, Easley DJ. Health-related quality of life in pediatric patients with irritable bowel 
syndrome: a comparative analysis. J.Dev.Behav.Pediatr. 2006;27(6):451-458. 
52. Rey E, Garcia-Alonso MO, Moreno-Ortega M, Alvarez-Sanchez A, Diaz-Rubio M. Determinants 
of quality of life in irritable bowel syndrome. Journal of clinical gastroenterology. Oct 
2008;42(9):1003-1009. 
53. Johansson PA, Farup PG, Bracco A, Vandvik PO. How does comorbidity affect cost of health 
care in patients with irritable bowel syndrome? A cohort study in general practice. BMC 
gastroenterology. 2010;10:31. 
54. Hillila MT, Siivola MT, Farkkila MA. Comorbidity and use of health-care services among 




55. Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A Diet Low in FODMAPs Reduces 
Symptoms of Irritable Bowel Syndrome. Gastroenterology. Sep 24 2013. 
56. Simren M, Barbara G, Flint HJ, Spiegel BM, Spiller RC, Vanner S, Verdu EF, Whorwell PJ, 
Zoetendal EG. Intestinal microbiota in functional bowel disorders: a Rome foundation report. 
Gut. Jan 2013;62(1):159-176. 
57. Saps M, Pensabene L, Di Martino L, Staiano A, Wechsler J, Zheng X, Di Lorenzo C. Post-
infectious functional gastrointestinal disorders in children. The Journal of pediatrics. Jun 
2008;152(6):812-816, 816 e811. 
58. Marshall JK, Thabane M, Garg AX, Clark WF, Moayyedi P, Collins SM, Investigators WHS. Eight 
year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial 
dysentery. Gut. May 1, 2010 2010;59(5):605-611. 
59. Gwee KA, Graham JC, McKendrick MW, Collins SM, Marshall JS, Walters SJ, Read NW. 
Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet. Jan 
20 1996;347(8995):150-153. 
60. Neal KR, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: a six year 
follow up study. Gut. Sep 2002;51(3):410-413. 
61. Jones MP, Dilley JB, Drossman D, Crowell MD. Brain-gut connections in functional GI 
disorders: anatomic and physiologic relationships. Neurogastroenterol Motil. Feb 
2006;18(2):91-103. 
62. Stasi C, Rosselli M, Bellini M, Laffi G, Milani S. Altered neuro-endocrine-immune pathways in 
the irritable bowel syndrome: the top-down and the bottom-up model. Journal of 
gastroenterology. Nov 2012;47(11):1177-1185. 
63. Tanaka Y, Kanazawa M, Fukudo S, Drossman DA. Biopsychosocial model of irritable bowel 
syndrome. J.Neurogastroenterol.Motil. 2011;17(2):131-139. 
64. Bouin M, Plourde V, Boivin M, Riberdy M, Lupien F, Laganiere M, Verrier P, Poitras P. Rectal 
distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and 
predictive values of pain sensory thresholds. Gastroenterology. Jun 2002;122(7):1771-1777. 
65. Posserud I, Syrous A, Lindstrom L, Tack J, Abrahamsson H, Simren M. Altered rectal 
perception in irritable bowel syndrome is associated with symptom severity. 
Gastroenterology. 2007;133(4):1113-1123. 
66. Guthrie E, Barlow J, Fernandes L, Ratcliffe J, Read N, Thompson DG, Tomenson B, Creed F. 
Changes in tolerance to rectal distension correlate with changes in psychological state in 
patients with severe irritable bowel syndrome. Psychosom.Med. 2004;66(4):578-582. 
67. Bouin M, Meunier P, Riberdy-Poitras M, Poitras P. Pain hypersensitivity in patients with 
functional gastrointestinal disorders: a gastrointestinal-specific defect or a general systemic 
condition? Dig.Dis.Sci. 2001;46(11):2542-2548. 
68. Caldarella MP, Giamberardino MA, Sacco F, Affaitati G, Milano A, Lerza R, Balatsinou C, 
Laterza F, Pierdomenico SD, Cuccurullo F, Neri M. Sensitivity disturbances in patients with 
irritable bowel syndrome and fibromyalgia. Am.J.Gastroenterol. 2006;101(12):2782-2789. 
69. Moshiree B, Price DD, Robinson ME, Gaible R, Verne GN. Thermal and visceral 
hypersensitivity in irritable bowel syndrome patients with and without fibromyalgia. 
Clin.J.Pain. 2007;23(4):323-330. 
70. Zhou Q, Fillingim RB, Riley JL, III, Verne GN. Ischemic hypersensitivity in irritable bowel 
syndrome patients. Pain Med. 2010;11(11):1619-1627. 
71. Verne GN, Robinson ME, Price DD. Hypersensitivity to visceral and cutaneous pain in the 
irritable bowel syndrome. Pain. 2001;93(1):7-14. 
72. Di Lorenzo C, Youssef NN, Sigurdsson L, Scharff L, Griffiths J, Wald A. Visceral hyperalgesia in 
children with functional abdominal pain. The Journal of pediatrics. Dec 2001;139(6):838-843. 
73. Faure C, Wieckowska A. Somatic referral of visceral sensations and rectal sensory threshold 




74. Halac U, Noble A, Faure C. Rectal sensory threshold for pain is a diagnostic marker of irritable 
bowel syndrome and functional abdominal pain in children. The Journal of pediatrics. Jan 
2010;156(1):60-65 e61. 
75. Alfven G. The pressure pain threshold (PPT) of certain muscles in children suffering from 
recurrent abdominal pain of non-organic origin. An algometric study. Acta paediatrica (Oslo, 
Norway : 1992). May 1993;82(5):481-483. 
76. Duarte MA, Goulart EM, Penna FJ. Pressure pain threshold in children with recurrent 
abdominal pain. Journal of pediatric gastroenterology and nutrition. Sep 2000;31(3):280-285. 
77. Williams AE, Heitkemper M, Self MM, Czyzewski DI, Shulman RJ. Endogenous inhibition of 
somatic pain is impaired in girls with irritable bowel syndrome compared with healthy girls. 
The journal of pain : official journal of the American Pain Society. Sep 2013;14(9):921-930. 
78. Zohsel K, Hohmeister J, Flor H, Hermann C. Somatic pain sensitivity in children with recurrent 
abdominal pain. Am.J.Gastroenterol. 2008;103(6):1517-1523. 
79. Nielsen CS, Staud R, Price DD. Individual differences in pain sensitivity: measurement, 
causation, and consequences. The journal of pain : official journal of the American Pain 
Society. Mar 2009;10(3):231-237. 
80. Fillingim RB. Individual differences in pain responses. Current rheumatology reports. Oct 
2005;7(5):342-347. 
81. Hastie BA, Riley JL, 3rd, Robinson ME, Glover T, Campbell CM, Staud R, Fillingim RB. Cluster 
analysis of multiple experimental pain modalities. Pain. Aug 2005;116(3):227-237. 
82. Nussbaum EL, Downes L. Reliability of clinical pressure-pain algometric measurements 
obtained on consecutive days. Physical therapy. Feb 1998;78(2):160-169. 
83. Persson AL, Brogardh C, Sjolund BH. Tender or not tender: test-retest repeatability of 
pressure pain thresholds in the trapezius and deltoid muscles of healthy women. Journal of 
rehabilitation medicine : official journal of the UEMS European Board of Physical and 
Rehabilitation Medicine. Jan 2004;36(1):17-27. 
84. Soee AB, Thomsen LL, Tornoe B, Skov L. Reliability of four experimental mechanical pain tests 
in children. Journal of pain research. 2013;6:103-110. 
85. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 
Mar 2011;152(3 Suppl):S2-15. 
86. Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by 
central neural plasticity. The journal of pain : official journal of the American Pain Society. Sep 
2009;10(9):895-926. 
87. Werner MU, Mjobo HN, Nielsen PR, Rudin A. Prediction of postoperative pain: a systematic 
review of predictive experimental pain studies. Anesthesiology. Jun 2010;112(6):1494-1502. 
88. Wilder-Smith CH. The balancing act: endogenous modulation of pain in functional 
gastrointestinal disorders. Gut. Nov 2011;60(11):1589-1599. 
89. Zhou Q, Fillingim RB, Riley JL, III, Malarkey WB, Verne GN. Central and peripheral 
hypersensitivity in the irritable bowel syndrome. Pain. 2010;148(3):454-461. 
90. Verne GN, Robinson ME, Vase L, Price DD. Reversal of visceral and cutaneous hyperalgesia by 
local rectal anesthesia in irritable bowel syndrome (IBS) patients. Pain. 2003;105(1-2):223-
230. 
91. Aggarwal A, Cutts TF, Abell TL, Cardoso S, Familoni B, Bremer J, Karas J. Predominant 
symptoms in irritable bowel syndrome correlate with specific autonomic nervous system 
abnormalities. Gastroenterology. Apr 1994;106(4):945-950. 
92. Camilleri M, Ford MJ. Functional gastrointestinal disease and the autonomic nervous system: 
a way ahead? Gastroenterology. Apr 1994;106(4):1114-1118. 
93. Kirchner A, Stefan H, Bastian K, Birklein F. Vagus nerve stimulation suppresses pain but has 
limited effects on neurogenic inflammation in humans. European journal of pain (London, 
England). Jul 2006;10(5):449-455. 
94. Lomax AE, Sharkey KA, Furness JB. The participation of the sympathetic innervation of the 
gastrointestinal tract in disease states. Neurogastroenterol Motil. Jan 2010;22(1):7-18. 
53 
 
95. Tache Y, Kiank C, Stengel A. A role for corticotropin-releasing factor in functional 
gastrointestinal disorders. Current gastroenterology reports. Aug 2009;11(4):270-277. 
96. Staud R, Cannon RC, Mauderli AP, Robinson ME, Price DD, Vierck CJ, Jr. Temporal summation 
of pain from mechanical stimulation of muscle tissue in normal controls and subjects with 
fibromyalgia syndrome. Pain. Mar 2003;102(1-2):87-95. 
97. Piche M, Arsenault M, Poitras P, Rainville P, Bouin M. Widespread hypersensitivity is related 
to altered pain inhibition processes in irritable bowel syndrome    Pain. 2010;148(1):49-58. 
98. Tillisch K, Mayer EA, Labus JS. Quantitative Meta-Analysis Identifies Brain Regions Activated 
During Rectal Distension in Irritable Bowel Syndrome. Gastroenterology. 2010. 
99. Verne GN, Himes NC, Robinson ME, Gopinath KS, Briggs RW, Crosson B, Price DD. Central 
representation of visceral and cutaneous hypersensitivity in the irritable bowel syndrome. 
Pain. 2003;103(1-2):99-110. 
100. Heaton KW, O'Donnell LJ, Braddon FE, Mountford RA, Hughes AO, Cripps PJ. Symptoms of 
irritable bowel syndrome in a British urban community: consulters and nonconsulters. 
Gastroenterology. Jun 1992;102(6):1962-1967. 
101. Simren M, Abrahamsson H, Svedlund J, Bjornsson ES. Quality of life in patients with irritable 
bowel syndrome seen in referral centers versus primary care: the impact of gender and 
predominant bowel pattern. Scandinavian journal of gastroenterology. May 2001;36(5):545-
552. 
102. van der Horst HE, van Dulmen AM, Schellevis FG, van Eijk JT, Fennis JF, Bleijenberg G. Do 
patients with irritable bowel syndrome in primary care really differ from outpatients with 
irritable bowel syndrome? Gut. Nov 1997;41(5):669-674. 
103. Ohman L, Simren M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune 
interactions. Nature reviews. Gastroenterology & hepatology. Mar 2010;7(3):163-173. 
104. Ringel Y, Maharshak N. The Intestinal Microbiota and Immune Function in the Pathogenesis 
of Irritable Bowel Syndrome. American journal of physiology. Gastrointestinal and liver 
physiology. Jul 25 2013. 
105. Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal 
symptoms: The FODMAP approach. J Gastroenterol Hepatol. Feb 2010;25(2):252-258. 
106. Wedlake L, A'Hern R, Russell D, Thomas K, Walters JR, Andreyev HJ. Systematic review: the 
prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients 
with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. Oct 
2009;30(7):707-717. 
107. Kidd M, Modlin IM, Gustafsson BI, Drozdov I, Hauso O, Pfragner R. Luminal regulation of 
normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, 
tastants, and olfactants. American journal of physiology. Gastrointestinal and liver 
physiology. Aug 2008;295(2):G260-272. 
108. Chitkara DK, van Tilburg MA, Blois-Martin N, Whitehead WE. Early life risk factors that 
contribute to irritable bowel syndrome in adults: a systematic review. Am J Gastroenterol. 
Mar 2008;103(3):765-774; quiz 775. 
109. Goodwin L, White PD, Hotopf M, Stansfeld SA, Clark C. Life course study of the etiology of 
self-reported irritable bowel syndrome in the 1958 British birth cohort. Psychosomatic 
medicine. Feb 2013;75(2):202-210. 
110. Nicholl BI, Halder SL, Macfarlane GJ, Thompson DG, O'Brien S, Musleh M, McBeth J. 
Psychosocial risk markers for new onset irritable bowel syndrome--results of a large 
prospective population-based study. Pain. Jul 2008;137(1):147-155. 
111. Drossman DA, Talley NJ, Leserman J, Olden KW, Barreiro MA. Sexual and physical abuse and 
gastrointestinal illness. Review and recommendations. Annals of internal medicine. Nov 15 
1995;123(10):782-794. 
112. Talley NJ, Fett SL, Zinsmeister AR, Melton LJ, 3rd. Gastrointestinal tract symptoms and self-
reported abuse: a population-based study. Gastroenterology. Oct 1994;107(4):1040-1049. 
54 
 
113. Ramchandani PG, Stein A, Hotopf M, Wiles NJ. Early parental and child predictors of 
recurrent abdominal pain at school age: results of a large population-based study. 
J.Am.Acad.Child Adolesc.Psychiatry. 2006;45(6):729-736. 
114. Helgeland H, Van Roy B, Sandvik L, Markestad T, Kristensen H. Paediatric functional 
abdominal pain: significance of child and maternal health. A prospective study. Acta 
paediatrica (Oslo, Norway : 1992). Nov 2011;100(11):1461-1467. 
115. Campo JV, Bridge J, Lucas A, Savorelli S, Walker L, Di Lorenzo C, Iyengar S, Brent DA. Physical 
and emotional health of mothers of youth with functional abdominal pain. Archives of 
pediatrics & adolescent medicine. Feb 2007;161(2):131-137. 
116. Kalantar JS, Locke GR, III, Zinsmeister AR, Beighley CM, Talley NJ. Familial aggregation of 
irritable bowel syndrome: a prospective study. Gut. 2003;52(12):1703-1707. 
117. Saito YA, Petersen GM, Larson JJ, Atkinson EJ, Fridley BL, de Andrade M, Locke GR, III, 
Zimmerman JM, Almazar-Elder AE, Talley NJ. Familial aggregation of irritable bowel 
syndrome: a family case-control study. Am.J.Gastroenterol. 2010;105(4):833-841. 
118. Nielsen CS, Knudsen GP, Steingrímsdóttir Ó. Twin studies of pain. Clinical Genetics. 
2012;82(4):331-340. 
119. D'Amato M. Genes and functional GI disorders: from casual to causal relationship. 
Neurogastroenterol Motil. Aug 2013;25(8):638-649. 
120. Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njølstad I. Cohort profile: The Tromsø 
Study. International Journal of Epidemiology. August 1, 2012 2012;41(4):961-967. 
121. Olden KW. Diagnosis of irritable bowel syndrome. Gastroenterology. 2002;122. 
122. Saito YA, Talley NJ, J. Melton L, Fett S, Zinsmeister AR, Locke GR. The effect of new diagnostic 
criteria for irritable bowel syndrome on community prevalence estimates. 
Neurogastroenterology & Motility. 2003;15(6):687-694. 
123. Sandanger I, Moum T, Ingebrigtsen G, Sorensen T, Dalgard OS, Bruusgaard D. The meaning 
and significance of caseness: the Hopkins Symptom Checklist-25 and the Composite 
International Diagnostic Interview. II. Soc.Psychiatry Psychiatr.Epidemiol. 1999;34(1):53-59. 
124. Sandanger I, Moum T, Ingebrigtsen G, Dalgard OS, Sorensen T, Bruusgaard D. Concordance 
between symptom screening and diagnostic procedure: the Hopkins Symptom Checklist-25 
and the Composite International Diagnostic Interview I. Soc.Psychiatry Psychiatr.Epidemiol. 
1998;33(7):345-354. 
125. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist 
(HSCL): a self-report symptom inventory. Behav.Sci. 1974;19(1):1-15. 
126. Strand BH, Dalgard OS, Tambs K, Rognerud M. Measuring the mental health status of the 
Norwegian population: a comparison of the instruments SCL-25, SCL-10, SCL-5 and MHI-5 
(SF-36). Nord.J.Psychiatry. 2003;57(2):113-118. 
127. Angold A, Costello E, Messer S, Pickles A, Winder F, Silver D. Development of a short 
questionnaire for use in epidemiological studies of depression in children and adolescents. 
International Journal of Methods in Psychiatric Research. 1995;5:237 - 249. 
128. Angold A, Erkanli A, Silberg J, Eaves L, Costello EJ. Depression scale scores in 8-17-year-olds: 
effects of age and gender. Journal of child psychology and psychiatry, and allied disciplines. 
Nov 2002;43(8):1052-1063. 
129. Thapar A, McGuffin P. Validity of the shortened Mood and Feelings Questionnaire in a 
community sample of children and adolescents: a preliminary research note. Psychiatry Res. 
1998;81:259 - 268. 
130. Price DD, Bush FM, Long S, Harkins SW. A comparison of pain measurement characteristics of 
mechanical visual analogue and simple numerical rating scales. Pain. Feb 1994;56(2):217-
226. 
131. Greenspan JD, Slade GD, Bair E, Dubner R, Fillingim RB, Ohrbach R, Knott C, Diatchenko L, Liu 
Q, Maixner W. Pain sensitivity and autonomic factors associated with development of TMD: 
the OPPERA prospective cohort study. The journal of pain : official journal of the American 
Pain Society. Dec 2013;14(12 Suppl):T63-74.e61-66. 
55 
 
132. Price DD, Craggs JG, Zhou Q, Verne GN, Perlstein WM, Robinson ME. Widespread 
hyperalgesia in irritable bowel syndrome is dynamically maintained by tonic visceral impulse 
input and placebo/nocebo factors: evidence from human psychophysics, animal models, and 
neuroimaging. Neuroimage. 2009;47(3):995-1001. 
133. Chang L, Mayer EA, Johnson T, Fitzgerald LZ, Naliboff B. Differences in somatic perception in 
female patients with irritable bowel syndrome with and without fibromyalgia. Pain. 
2000;84(2-3):297-307. 
134. Wilder-Smith CH, Robert-Yap J. Abnormal endogenous pain modulation and somatic and 
visceral hypersensitivity in female patients with irritable bowel syndrome. World journal of 
gastroenterology : WJG. Jul 21 2007;13(27):3699-3704. 
135. Rodrigues AC, Nicholas VG, Schmidt S, Mauderli AP. Hypersensitivity to cutaneous thermal 
nociceptive stimuli in irritable bowel syndrome. Pain. 2005;115(1-2):5-11. 
136. Zhou Q, Fillingim RB, Riley JL, III, Verne GN. Thermal hypersensitivity in a subset of irritable 
bowel syndrome patients. World J.Gastroenterol. 2009;15(26):3254-3260. 
137. van der Veek PP, Van Rood YR, Masclee AA. Symptom severity but not psychopathology 
predicts visceral hypersensitivity in irritable bowel syndrome. Clinical gastroenterology and 
hepatology : the official clinical practice journal of the American Gastroenterological 
Association. Mar 2008;6(3):321-328. 
138. Lee JE, Watson D, Frey-Law LA. Psychological factors predict local and referred experimental 
muscle pain: a cluster analysis in healthy adults. European journal of pain (London, England). 
Jul 2013;17(6):903-915. 
139. de Medeiros MT, Carvalho AF, Oliveira Lima JW, Dos Santos AA, de Oliveira RB, Nobre ESMA. 
Impact of depressive symptoms on visceral sensitivity among patients with different 
subtypes of irritable bowel syndrome. J.Nerv.Ment.Dis. 2008;196(9):711-714. 
140. Sabate JM, Veyrac M, Mion F, Siproudhis L, Ducrotte P, Zerbib F, Grimaud JC, Dapoigny M, 
Dyard F, Coffin B. Relationship between rectal sensitivity, symptoms intensity and quality of 
life in patients with irritable bowel syndrome. Aliment.Pharmacol.Ther. 2008;28(4):484-490. 
141. Dufton LM, Dunn MJ, Slosky LS, Compas BE. Self-reported and laboratory-based responses to 
stress in children with recurrent pain and anxiety. Journal of pediatric psychology. Jan 
2011;36(1):95-105. 
142. Saito YA, Schoenfeld P, Locke GR, III. The epidemiology of irritable bowel syndrome in North 
America: a systematic review. Am.J.Gastroenterol. 2002;97(8):1910-1915. 
143. Park DW, Lee OY, Shim SG, Jun DW, Lee KN, Kim HY, Lee HL, Yoon BC, Choi HS. The 
Differences in Prevalence and Sociodemographic Characteristics of Irritable Bowel Syndrome 
According to Rome II and Rome III. J.Neurogastroenterol.Motil. 2010;16(2):186-193. 
144. Hillila MT, Farkkila MA. Prevalence of irritable bowel syndrome according to different 
diagnostic criteria in a non-selected adult population. Aliment.Pharmacol.Ther. 
2004;20(3):339-345. 
145. Johnsen R, Jacobsen BK, Forde OH. Associations between symptoms of irritable colon and 
psychological and social conditions and lifestyle. British medical journal (Clinical research 
ed.). Jun 21 1986;292(6536):1633-1635. 
146. Gulewitsch MD, Enck P, Schwille-Kiuntke J, Weimer K, Schlarb AA. Rome III criteria in parents' 
hands: pain-related functional gastrointestinal disorders in community children and 
associations with somatic complaints and mental health. European journal of 
gastroenterology & hepatology. Oct 2013;25(10):1223-1229. 
147. Endo Y, Shoji T, Fukudo S, Machida T, Noda S, Hongo M. The features of adolescent irritable 
bowel syndrome in Japan. J.Gastroenterol.Hepatol. 2011;26 Suppl 3:106-109. 
148. Zhou H, Yao M, Cheng GY, Chen YP, Li DG. Prevalence and associated factors of functional 
gastrointestinal disorders and bowel habits in Chinese adolescents: a school-based study. 
J.Pediatr.Gastroenterol.Nutr. 2011;53(2):168-173. 
149. Kang JY. Systematic review: the influence of geography and ethnicity in irritable bowel 
syndrome. Aliment Pharmacol Ther. Mar 15 2005;21(6):663-676. 
56 
 
150. Mykletun A, Jacka F, Williams L, Pasco J, Henry M, Nicholson GC, Kotowicz MA, Berk M. 
Prevalence of mood and anxiety disorder in self reported irritable bowel syndrome (IBS). An 
epidemiological population based study of women. BMC gastroenterology. 2010;10:88. 
151. Campo JV, Bridge J, Ehmann M, Altman S, Lucas A, Birmaher B, Di Lorenzo C, Iyengar S, Brent 
DA. Recurrent abdominal pain, anxiety, and depression in primary care. Pediatrics. Apr 
2004;113(4):817-824. 
152. Campo Jv Fau - Bridge J, Bridge J Fau - Ehmann M, Ehmann M Fau - Altman S, Altman S Fau - 
Lucas A, Lucas A Fau - Birmaher B, Birmaher B Fau - Di Lorenzo C, Di Lorenzo C Fau - Iyengar 
S, Iyengar S Fau - Brent DA, Brent DA. Recurrent abdominal pain, anxiety, and depression in 
primary care. Pediatrics. 20040402 DCOM- 20040513 2004;113(1098-4275 (Electronic)):817-
824. 
153. Heitkemper M, Cain K, Shulman R, Burr R, Poppe A, Jarrett M. Subtypes of Irritable Bowel 
Syndrome Based on Abdominal Pain/Discomfort Severity and Bowel Pattern. Digestive 
Diseases and Sciences. 2011;56(7):2050-2058. 
154. Bond B, Quinlan J, Dukes GE, Mearin F, Clouse RE, Alpers DH. Irritable bowel syndrome: more 
than abdominal pain and bowel habit abnormalities. Clinical gastroenterology and 
hepatology : the official clinical practice journal of the American Gastroenterological 
Association. Jan 2009;7(1):73-79. 
155. Koloski NA, Boyce PM, Jones MP, Talley NJ. What level of IBS symptoms drives impairment in 
health-related quality of life in community subjects with irritable bowel syndrome? Are 
current IBS symptom thresholds clinically meaningful? Qual Life Res. Jun 2012;21(5):829-836. 
156. Alpers DH. Multidimensionality of symptom complexes in irritable bowel syndrome and 
other functional gastrointestinal disorders. Journal of psychosomatic research. Jun 
2008;64(6):567-572. 
157. Spiegel BM, Bolus R, Agarwal N, Sayuk G, Harris LA, Lucak S, Esrailian E, Chey WD, Lembo A, 
Karsan H, Tillisch K, Talley J, Chang L. Measuring symptoms in the irritable bowel syndrome: 
development of a framework for clinical trials. Aliment Pharmacol Ther. Nov 
2010;32(10):1275-1291. 
158. Spiegel BM, Gralnek IM, Bolus R, Chang L, Dulai GS, Mayer EA, Naliboff B. Clinical 
determinants of health-related quality of life in patients with irritable bowel syndrome. 
Archives of internal medicine. Sep 13 2004;164(16):1773-1780. 
159. Whitehead WE, Drossman DA. Validation of symptom-based diagnostic criteria for irritable 
bowel syndrome: a critical review. Am.J.Gastroenterol. 2010;105(4):814-820. 
160. Nielsen CS, Stubhaug A, Price DD, Vassend O, Czajkowski N, Harris JR. Individual differences 
in pain sensitivity: genetic and environmental contributions. Pain. May 2008;136(1-2):21-29. 
161. Rosier EM, Iadarola MJ, Coghill RC. Reproducibility of pain measurement and pain 
perception. Pain. Jul 2002;98(1-2):205-216. 
162. Quiton RL, Greenspan JD. Across- and within-session variability of ratings of painful contact 
heat stimuli. Pain. Jul 15 2008;137(2):245-256. 
 
